Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastrointestinal Microbiome | 59 | 2024 | 492 | 13.130 |
Why?
|
Intestinal Mucosa | 111 | 2021 | 804 | 12.970 |
Why?
|
Inflammatory Bowel Diseases | 29 | 2021 | 566 | 7.040 |
Why?
|
Microbiota | 25 | 2023 | 396 | 5.970 |
Why?
|
Heat-Shock Proteins | 27 | 2016 | 181 | 5.240 |
Why?
|
Dysbiosis | 17 | 2024 | 77 | 5.050 |
Why?
|
Colon | 40 | 2021 | 505 | 4.770 |
Why?
|
Sodium-Hydrogen Exchangers | 39 | 2010 | 77 | 4.640 |
Why?
|
Diet | 19 | 2022 | 442 | 3.880 |
Why?
|
Colitis | 16 | 2021 | 241 | 3.870 |
Why?
|
Gastrointestinal Tract | 15 | 2024 | 190 | 3.820 |
Why?
|
Animals | 262 | 2024 | 27233 | 3.750 |
Why?
|
Intestines | 30 | 2019 | 416 | 3.360 |
Why?
|
Diet, High-Fat | 18 | 2022 | 119 | 3.200 |
Why?
|
Mice | 131 | 2024 | 11710 | 3.190 |
Why?
|
Intestine, Small | 15 | 2018 | 304 | 3.010 |
Why?
|
Inflammation | 32 | 2024 | 961 | 2.980 |
Why?
|
Obesity | 16 | 2022 | 972 | 2.950 |
Why?
|
HSP70 Heat-Shock Proteins | 12 | 2017 | 114 | 2.810 |
Why?
|
Lipid Metabolism | 11 | 2023 | 200 | 2.810 |
Why?
|
Interleukin-10 | 13 | 2021 | 151 | 2.730 |
Why?
|
Cystic Fibrosis | 8 | 2015 | 117 | 2.660 |
Why?
|
Epithelial Cells | 32 | 2023 | 686 | 2.650 |
Why?
|
Sodium | 32 | 2013 | 331 | 2.490 |
Why?
|
Bacteria | 16 | 2024 | 468 | 2.480 |
Why?
|
Sirtuin 1 | 8 | 2021 | 32 | 2.450 |
Why?
|
Neoplasm Proteins | 14 | 2016 | 539 | 2.400 |
Why?
|
Circadian Clocks | 5 | 2023 | 59 | 2.310 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 10 | 2015 | 57 | 2.210 |
Why?
|
Dietary Fats | 9 | 2016 | 136 | 2.100 |
Why?
|
Glutamine | 9 | 2011 | 79 | 2.080 |
Why?
|
Sinusitis | 5 | 2017 | 213 | 2.080 |
Why?
|
Mice, Inbred C57BL | 57 | 2024 | 3202 | 2.060 |
Why?
|
Autophagy | 7 | 2019 | 154 | 2.020 |
Why?
|
Disease Models, Animal | 46 | 2024 | 2346 | 1.970 |
Why?
|
Paranasal Sinuses | 4 | 2017 | 60 | 1.940 |
Why?
|
NF-kappa B | 12 | 2022 | 464 | 1.850 |
Why?
|
Vitamin D | 6 | 2022 | 267 | 1.790 |
Why?
|
AMP-Activated Protein Kinases | 5 | 2022 | 64 | 1.770 |
Why?
|
Humans | 196 | 2024 | 88611 | 1.750 |
Why?
|
Feces | 19 | 2024 | 326 | 1.750 |
Why?
|
Tumor Necrosis Factor-alpha | 16 | 2022 | 699 | 1.730 |
Why?
|
Colitis, Ulcerative | 14 | 2024 | 723 | 1.730 |
Why?
|
Rats | 70 | 2021 | 4041 | 1.650 |
Why?
|
Ileum | 27 | 2016 | 162 | 1.640 |
Why?
|
Metagenome | 10 | 2024 | 103 | 1.630 |
Why?
|
Adipose Tissue | 11 | 2022 | 259 | 1.610 |
Why?
|
RNA, Messenger | 38 | 2022 | 2009 | 1.610 |
Why?
|
Liver | 13 | 2023 | 1244 | 1.590 |
Why?
|
Plant Extracts | 7 | 2021 | 244 | 1.520 |
Why?
|
Adipocytes | 6 | 2021 | 163 | 1.500 |
Why?
|
Host-Pathogen Interactions | 8 | 2021 | 235 | 1.500 |
Why?
|
Bile Acids and Salts | 9 | 2024 | 66 | 1.490 |
Why?
|
Colonic Neoplasms | 11 | 2020 | 566 | 1.480 |
Why?
|
Cells, Cultured | 40 | 2017 | 2879 | 1.470 |
Why?
|
Signal Transduction | 28 | 2020 | 3368 | 1.460 |
Why?
|
Apoptosis | 20 | 2016 | 1718 | 1.420 |
Why?
|
Circadian Rhythm | 4 | 2022 | 303 | 1.410 |
Why?
|
Fecal Microbiota Transplantation | 7 | 2021 | 64 | 1.410 |
Why?
|
Butyrates | 7 | 2016 | 46 | 1.360 |
Why?
|
Cell Line | 38 | 2019 | 2498 | 1.360 |
Why?
|
HMGB1 Protein | 5 | 2019 | 16 | 1.340 |
Why?
|
Anti-Bacterial Agents | 17 | 2024 | 777 | 1.320 |
Why?
|
Cyclic AMP | 16 | 2013 | 274 | 1.320 |
Why?
|
Precision Medicine | 3 | 2020 | 407 | 1.290 |
Why?
|
Neointima | 4 | 2020 | 14 | 1.240 |
Why?
|
RNA, Ribosomal, 16S | 17 | 2023 | 247 | 1.240 |
Why?
|
Gene Expression Regulation | 16 | 2021 | 1977 | 1.210 |
Why?
|
Cytokines | 18 | 2021 | 801 | 1.190 |
Why?
|
Interferon-gamma | 7 | 2010 | 452 | 1.190 |
Why?
|
Gastrointestinal Diseases | 3 | 2015 | 149 | 1.190 |
Why?
|
Irritable Bowel Syndrome | 3 | 2017 | 46 | 1.180 |
Why?
|
Heat-Shock Response | 6 | 2011 | 49 | 1.170 |
Why?
|
Sumoylation | 5 | 2016 | 18 | 1.170 |
Why?
|
Male | 117 | 2024 | 42012 | 1.170 |
Why?
|
Endothelial Cells | 7 | 2017 | 454 | 1.160 |
Why?
|
HSP27 Heat-Shock Proteins | 9 | 2012 | 33 | 1.150 |
Why?
|
Probiotics | 7 | 2020 | 86 | 1.150 |
Why?
|
Fatty Acids | 4 | 2019 | 134 | 1.130 |
Why?
|
Intestinal Absorption | 16 | 2018 | 124 | 1.110 |
Why?
|
Fatty Acids, Volatile | 5 | 2019 | 32 | 1.080 |
Why?
|
Carotid Artery Injuries | 3 | 2020 | 22 | 1.060 |
Why?
|
Rats, Sprague-Dawley | 28 | 2021 | 1237 | 1.040 |
Why?
|
Caco-2 Cells | 23 | 2023 | 123 | 1.040 |
Why?
|
Microvilli | 23 | 2010 | 43 | 1.030 |
Why?
|
Biodiversity | 5 | 2019 | 202 | 1.030 |
Why?
|
Toll-Like Receptor 4 | 4 | 2016 | 91 | 1.030 |
Why?
|
Gene Expression | 15 | 2015 | 1312 | 1.020 |
Why?
|
Stress, Physiological | 6 | 2017 | 231 | 1.020 |
Why?
|
Mice, Knockout | 27 | 2021 | 1988 | 1.010 |
Why?
|
Oxidants | 10 | 2012 | 86 | 1.010 |
Why?
|
Diarrhea | 15 | 2009 | 182 | 1.000 |
Why?
|
Jejunum | 16 | 2016 | 80 | 1.000 |
Why?
|
Adiponectin | 2 | 2015 | 23 | 0.990 |
Why?
|
Rhinitis | 2 | 2017 | 177 | 0.960 |
Why?
|
Membrane Proteins | 12 | 2020 | 1214 | 0.950 |
Why?
|
Bilophila | 2 | 2015 | 3 | 0.950 |
Why?
|
Paneth Cells | 2 | 2023 | 10 | 0.940 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2016 | 1167 | 0.920 |
Why?
|
Sodium-Hydrogen Exchanger 3 | 20 | 2010 | 32 | 0.920 |
Why?
|
Bacteroides thetaiotaomicron | 1 | 2023 | 4 | 0.920 |
Why?
|
Cell Proliferation | 11 | 2020 | 1647 | 0.910 |
Why?
|
Pouchitis | 5 | 2024 | 44 | 0.910 |
Why?
|
Peptide YY | 1 | 2023 | 9 | 0.910 |
Why?
|
Lipopolysaccharides | 7 | 2019 | 292 | 0.910 |
Why?
|
Candida | 1 | 2023 | 18 | 0.900 |
Why?
|
3T3-L1 Cells | 5 | 2015 | 34 | 0.890 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2016 | 106 | 0.890 |
Why?
|
Blotting, Western | 22 | 2019 | 797 | 0.880 |
Why?
|
Peptide Fragments | 3 | 2023 | 460 | 0.880 |
Why?
|
Proctocolectomy, Restorative | 5 | 2022 | 87 | 0.870 |
Why?
|
Pseudomonas Infections | 5 | 2017 | 99 | 0.860 |
Why?
|
Wound Healing | 4 | 2021 | 356 | 0.860 |
Why?
|
Muscle, Skeletal | 5 | 2021 | 464 | 0.850 |
Why?
|
Antifungal Agents | 1 | 2023 | 119 | 0.850 |
Why?
|
Cytoprotection | 6 | 2017 | 47 | 0.840 |
Why?
|
Panax | 8 | 2017 | 170 | 0.830 |
Why?
|
Insulin Resistance | 5 | 2016 | 364 | 0.820 |
Why?
|
Kruppel-Like Transcription Factors | 4 | 2022 | 98 | 0.810 |
Why?
|
Pseudomonas aeruginosa | 12 | 2017 | 201 | 0.800 |
Why?
|
Amyloidosis | 5 | 2024 | 124 | 0.790 |
Why?
|
Models, Animal | 7 | 2018 | 276 | 0.790 |
Why?
|
Endocytosis | 5 | 2009 | 180 | 0.780 |
Why?
|
Macrophages | 8 | 2021 | 572 | 0.780 |
Why?
|
MAP Kinase Signaling System | 4 | 2015 | 197 | 0.770 |
Why?
|
Insulin | 7 | 2016 | 1155 | 0.750 |
Why?
|
Colonic Pouches | 5 | 2022 | 67 | 0.740 |
Why?
|
Colorectal Neoplasms | 5 | 2023 | 970 | 0.740 |
Why?
|
Molecular Typing | 1 | 2020 | 17 | 0.740 |
Why?
|
Ruminococcus | 1 | 2020 | 2 | 0.740 |
Why?
|
Sepsis | 10 | 2018 | 317 | 0.730 |
Why?
|
Chloramines | 13 | 2006 | 20 | 0.730 |
Why?
|
Metabolic Diseases | 2 | 2020 | 52 | 0.730 |
Why?
|
Synaptotagmin I | 3 | 2009 | 16 | 0.730 |
Why?
|
Protein Biosynthesis | 6 | 2010 | 391 | 0.720 |
Why?
|
Calcium | 15 | 2009 | 1170 | 0.710 |
Why?
|
HSP72 Heat-Shock Proteins | 13 | 2005 | 23 | 0.690 |
Why?
|
Constipation | 3 | 2017 | 63 | 0.690 |
Why?
|
Chlorides | 8 | 2008 | 103 | 0.690 |
Why?
|
Transcription, Genetic | 5 | 2016 | 1156 | 0.690 |
Why?
|
Communications Media | 1 | 2019 | 2 | 0.690 |
Why?
|
Carotid Arteries | 2 | 2020 | 127 | 0.690 |
Why?
|
Molecular Chaperones | 11 | 2016 | 112 | 0.690 |
Why?
|
Proteolysis | 3 | 2016 | 108 | 0.670 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 5 | 2008 | 79 | 0.670 |
Why?
|
Organic Cation Transport Proteins | 2 | 2010 | 13 | 0.670 |
Why?
|
Acetylcysteine | 3 | 2012 | 70 | 0.660 |
Why?
|
Female | 52 | 2024 | 45759 | 0.660 |
Why?
|
Serotonin | 5 | 2017 | 221 | 0.660 |
Why?
|
Nasal Mucosa | 3 | 2017 | 191 | 0.660 |
Why?
|
Phosphorylation | 15 | 2017 | 1129 | 0.650 |
Why?
|
Dose-Response Relationship, Drug | 17 | 2017 | 1945 | 0.640 |
Why?
|
Ezetimibe | 2 | 2015 | 35 | 0.640 |
Why?
|
Carrier Proteins | 11 | 2002 | 679 | 0.640 |
Why?
|
Diabetic Angiopathies | 2 | 2016 | 37 | 0.640 |
Why?
|
Steroid Hydroxylases | 2 | 2017 | 14 | 0.630 |
Why?
|
Oxidative Stress | 9 | 2014 | 457 | 0.630 |
Why?
|
Intestinal Diseases | 2 | 2017 | 79 | 0.630 |
Why?
|
Choroidal Neovascularization | 3 | 2023 | 32 | 0.630 |
Why?
|
Tight Junctions | 7 | 2017 | 150 | 0.620 |
Why?
|
Biological Transport | 20 | 2013 | 400 | 0.620 |
Why?
|
Genetic Vectors | 2 | 2013 | 446 | 0.610 |
Why?
|
Cytochrome P450 Family 2 | 1 | 2017 | 4 | 0.610 |
Why?
|
Micronutrients | 1 | 2017 | 18 | 0.610 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 123 | 0.610 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2017 | 42 | 0.610 |
Why?
|
MicroRNAs | 7 | 2019 | 551 | 0.600 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2017 | 4 | 0.600 |
Why?
|
Antioxidants | 2 | 2017 | 225 | 0.600 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2017 | 44 | 0.600 |
Why?
|
Hepatocytes | 2 | 2015 | 128 | 0.600 |
Why?
|
Azoxymethane | 2 | 2017 | 82 | 0.600 |
Why?
|
Fatty Liver | 3 | 2015 | 132 | 0.600 |
Why?
|
Anti-Inflammatory Agents | 4 | 2015 | 342 | 0.600 |
Why?
|
Dietary Fiber | 5 | 2021 | 44 | 0.590 |
Why?
|
Endothelial Progenitor Cells | 4 | 2019 | 13 | 0.590 |
Why?
|
Receptors, Serotonin, 5-HT3 | 1 | 2017 | 15 | 0.590 |
Why?
|
Dextran Sulfate | 7 | 2017 | 68 | 0.580 |
Why?
|
Transfection | 15 | 2012 | 914 | 0.580 |
Why?
|
Energy Intake | 2 | 2017 | 97 | 0.580 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2017 | 48 | 0.580 |
Why?
|
Chronic Disease | 11 | 2024 | 948 | 0.570 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2016 | 1256 | 0.570 |
Why?
|
Diabetes Mellitus, Experimental | 8 | 2017 | 190 | 0.570 |
Why?
|
Immunity, Mucosal | 5 | 2019 | 69 | 0.570 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2005 | 242 | 0.570 |
Why?
|
Wnt-5a Protein | 1 | 2016 | 10 | 0.560 |
Why?
|
Autoimmunity | 2 | 2016 | 168 | 0.560 |
Why?
|
Gastrointestinal Motility | 2 | 2016 | 25 | 0.560 |
Why?
|
Symporters | 3 | 2006 | 105 | 0.560 |
Why?
|
Immune Tolerance | 3 | 2021 | 338 | 0.560 |
Why?
|
Adiposity | 6 | 2016 | 77 | 0.560 |
Why?
|
Adenosine | 4 | 2024 | 238 | 0.550 |
Why?
|
Quinolones | 2 | 2014 | 60 | 0.550 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2016 | 3 | 0.540 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2016 | 40 | 0.540 |
Why?
|
Lipolysis | 1 | 2015 | 23 | 0.540 |
Why?
|
Cell Survival | 12 | 2020 | 980 | 0.540 |
Why?
|
Vitamin D Deficiency | 1 | 2017 | 103 | 0.530 |
Why?
|
Inflammation Mediators | 5 | 2017 | 155 | 0.530 |
Why?
|
Alzheimer Disease | 4 | 2024 | 482 | 0.530 |
Why?
|
Hypertension | 4 | 2024 | 733 | 0.520 |
Why?
|
Glucose | 12 | 2023 | 630 | 0.520 |
Why?
|
Neoplasms | 6 | 2020 | 3009 | 0.520 |
Why?
|
Models, Cardiovascular | 1 | 2016 | 104 | 0.520 |
Why?
|
Enterotoxins | 3 | 2004 | 20 | 0.520 |
Why?
|
Protein Kinases | 2 | 2016 | 212 | 0.510 |
Why?
|
Energy Metabolism | 6 | 2021 | 278 | 0.510 |
Why?
|
Vitamins | 4 | 2022 | 82 | 0.510 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 6 | 0.510 |
Why?
|
Hydrogen-Ion Concentration | 17 | 2014 | 499 | 0.510 |
Why?
|
Exercise | 1 | 2018 | 322 | 0.510 |
Why?
|
Mitochondria, Muscle | 3 | 2021 | 26 | 0.510 |
Why?
|
Down-Regulation | 11 | 2019 | 520 | 0.510 |
Why?
|
Alprostadil | 4 | 2013 | 25 | 0.500 |
Why?
|
Aminophenols | 1 | 2014 | 4 | 0.500 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2012 | 386 | 0.500 |
Why?
|
DNA, Bacterial | 7 | 2020 | 238 | 0.500 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2015 | 45 | 0.500 |
Why?
|
Azetidines | 1 | 2015 | 37 | 0.490 |
Why?
|
Dental Enamel | 2 | 2012 | 16 | 0.490 |
Why?
|
Crohn Disease | 4 | 2022 | 749 | 0.490 |
Why?
|
Time Factors | 20 | 2024 | 5319 | 0.490 |
Why?
|
Bacteroides | 4 | 2024 | 34 | 0.490 |
Why?
|
Electrolytes | 9 | 1996 | 52 | 0.480 |
Why?
|
Cell Movement | 5 | 2020 | 784 | 0.480 |
Why?
|
Aldosterone | 2 | 2008 | 56 | 0.470 |
Why?
|
Anticholesteremic Agents | 1 | 2015 | 137 | 0.470 |
Why?
|
Molecular Sequence Data | 15 | 2015 | 3029 | 0.470 |
Why?
|
Clostridium Infections | 1 | 2016 | 125 | 0.470 |
Why?
|
Hot Temperature | 4 | 2021 | 208 | 0.470 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2013 | 27 | 0.460 |
Why?
|
Toll-Like Receptor 2 | 3 | 2018 | 35 | 0.460 |
Why?
|
Respiratory Mucosa | 2 | 2014 | 88 | 0.460 |
Why?
|
Enzyme Inhibitors | 7 | 2011 | 646 | 0.460 |
Why?
|
Mentors | 1 | 2014 | 82 | 0.460 |
Why?
|
Antiporters | 3 | 2012 | 18 | 0.450 |
Why?
|
Transcriptome | 6 | 2024 | 623 | 0.450 |
Why?
|
Germ-Free Life | 7 | 2021 | 75 | 0.450 |
Why?
|
Diet, Western | 4 | 2023 | 39 | 0.450 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2017 | 222 | 0.450 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 5 | 2015 | 22 | 0.450 |
Why?
|
Actins | 7 | 2006 | 456 | 0.440 |
Why?
|
Bacterial Infections | 2 | 2018 | 184 | 0.440 |
Why?
|
Sus scrofa | 3 | 2013 | 50 | 0.440 |
Why?
|
Quorum Sensing | 3 | 2007 | 28 | 0.440 |
Why?
|
Amiloride | 16 | 2008 | 36 | 0.440 |
Why?
|
Respiratory System | 1 | 2013 | 116 | 0.440 |
Why?
|
Biota | 1 | 2013 | 20 | 0.440 |
Why?
|
Ion Transport | 7 | 2016 | 81 | 0.430 |
Why?
|
Lung | 5 | 2022 | 1243 | 0.430 |
Why?
|
Taurocholic Acid | 1 | 2012 | 6 | 0.430 |
Why?
|
Genetic Predisposition to Disease | 7 | 2017 | 2322 | 0.420 |
Why?
|
Gastroenterology | 2 | 2014 | 146 | 0.420 |
Why?
|
Up-Regulation | 7 | 2012 | 729 | 0.420 |
Why?
|
Bacillus subtilis | 3 | 2018 | 89 | 0.420 |
Why?
|
Adaptation, Physiological | 3 | 2006 | 316 | 0.420 |
Why?
|
Faculty, Medical | 1 | 2014 | 184 | 0.420 |
Why?
|
Wet Macular Degeneration | 2 | 2023 | 25 | 0.420 |
Why?
|
Metagenomics | 4 | 2020 | 88 | 0.420 |
Why?
|
Homeostasis | 5 | 2017 | 408 | 0.420 |
Why?
|
Cecum | 8 | 2020 | 68 | 0.420 |
Why?
|
Cardiovascular Diseases | 2 | 2016 | 707 | 0.420 |
Why?
|
Salmonella Infections | 3 | 2019 | 18 | 0.410 |
Why?
|
3' Untranslated Regions | 2 | 2010 | 95 | 0.410 |
Why?
|
Culture Media, Conditioned | 3 | 2009 | 103 | 0.410 |
Why?
|
Contractile Proteins | 1 | 2012 | 55 | 0.410 |
Why?
|
Intestine, Large | 2 | 2010 | 16 | 0.410 |
Why?
|
Antihypertensive Agents | 2 | 2024 | 244 | 0.410 |
Why?
|
Immunohistochemistry | 11 | 2014 | 1790 | 0.400 |
Why?
|
Adenoviridae | 1 | 2013 | 349 | 0.400 |
Why?
|
Autophagy-Related Protein 5 | 3 | 2016 | 11 | 0.400 |
Why?
|
Bacterial Physiological Phenomena | 2 | 2018 | 41 | 0.400 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 1240 | 0.390 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 2 | 2006 | 39 | 0.380 |
Why?
|
Mesalamine | 2 | 2005 | 87 | 0.380 |
Why?
|
Chickens | 14 | 2004 | 213 | 0.380 |
Why?
|
Polyamines | 1 | 2011 | 34 | 0.380 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 8 | 2015 | 891 | 0.380 |
Why?
|
Microdissection | 1 | 2010 | 18 | 0.380 |
Why?
|
Protein Binding | 9 | 2017 | 1484 | 0.370 |
Why?
|
Endothelium, Vascular | 5 | 2016 | 433 | 0.370 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 80 | 0.370 |
Why?
|
Salmonella typhimurium | 2 | 2008 | 32 | 0.370 |
Why?
|
Premature Birth | 1 | 2012 | 115 | 0.370 |
Why?
|
Milk | 3 | 2017 | 53 | 0.370 |
Why?
|
Atherosclerosis | 4 | 2015 | 255 | 0.360 |
Why?
|
Receptors, Androgen | 3 | 2016 | 121 | 0.360 |
Why?
|
Tryptases | 1 | 2010 | 12 | 0.360 |
Why?
|
Phosphoproteins | 4 | 2005 | 260 | 0.360 |
Why?
|
Genome, Human | 1 | 2015 | 767 | 0.360 |
Why?
|
Acute Lung Injury | 2 | 2022 | 64 | 0.360 |
Why?
|
Interleukin-8 | 4 | 2013 | 86 | 0.360 |
Why?
|
Pregnancy Complications, Cardiovascular | 4 | 2024 | 107 | 0.360 |
Why?
|
Dexamethasone | 3 | 2015 | 344 | 0.360 |
Why?
|
RNA, Small Interfering | 7 | 2010 | 559 | 0.360 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 6 | 2014 | 125 | 0.360 |
Why?
|
Transcription Factors | 6 | 2015 | 1647 | 0.360 |
Why?
|
Immunity, Innate | 5 | 2017 | 427 | 0.350 |
Why?
|
Tumor Cells, Cultured | 6 | 2011 | 1057 | 0.350 |
Why?
|
Lactobacillus plantarum | 1 | 2009 | 4 | 0.350 |
Why?
|
Angiotensin II | 2 | 2012 | 93 | 0.350 |
Why?
|
Protein Kinase C | 4 | 2011 | 268 | 0.350 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 743 | 0.350 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 1427 | 0.350 |
Why?
|
Cytoplasmic Granules | 1 | 2010 | 96 | 0.350 |
Why?
|
Symbiosis | 3 | 2023 | 122 | 0.350 |
Why?
|
Mice, Transgenic | 8 | 2024 | 1571 | 0.350 |
Why?
|
Genomics | 1 | 2015 | 747 | 0.340 |
Why?
|
Proteasome Inhibitors | 1 | 2009 | 52 | 0.340 |
Why?
|
Exercise Therapy | 2 | 2020 | 80 | 0.340 |
Why?
|
Ginsenosides | 4 | 2016 | 123 | 0.340 |
Why?
|
Dietary Supplements | 2 | 2022 | 130 | 0.340 |
Why?
|
Vitamin E | 2 | 2007 | 35 | 0.340 |
Why?
|
Cell Division | 5 | 2007 | 696 | 0.340 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 3 | 2015 | 9 | 0.340 |
Why?
|
Digestion | 2 | 2019 | 7 | 0.340 |
Why?
|
Prebiotics | 2 | 2020 | 8 | 0.330 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2020 | 127 | 0.330 |
Why?
|
Aminosalicylic Acids | 2 | 2005 | 41 | 0.330 |
Why?
|
Biological Evolution | 1 | 2017 | 950 | 0.330 |
Why?
|
Sequence Analysis, DNA | 4 | 2020 | 863 | 0.330 |
Why?
|
Adipogenesis | 3 | 2021 | 39 | 0.330 |
Why?
|
Zingiberaceae | 3 | 2017 | 9 | 0.330 |
Why?
|
Zanthoxylum | 3 | 2017 | 9 | 0.330 |
Why?
|
Actin Cytoskeleton | 1 | 2010 | 194 | 0.330 |
Why?
|
Mutation | 5 | 2015 | 4097 | 0.320 |
Why?
|
Phylogeny | 6 | 2015 | 1171 | 0.320 |
Why?
|
Viruses | 2 | 2022 | 78 | 0.320 |
Why?
|
Body Weight | 4 | 2021 | 455 | 0.320 |
Why?
|
Bacteroides fragilis | 3 | 2024 | 43 | 0.320 |
Why?
|
Pregnancy Outcome | 3 | 2024 | 253 | 0.320 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2012 | 659 | 0.310 |
Why?
|
Tissue Culture Techniques | 4 | 2013 | 81 | 0.310 |
Why?
|
Bacteriological Techniques | 2 | 2020 | 39 | 0.310 |
Why?
|
Organelle Biogenesis | 2 | 2019 | 6 | 0.310 |
Why?
|
Proto-Oncogene Proteins | 4 | 2018 | 661 | 0.310 |
Why?
|
Parathyroid Hormone | 1 | 2009 | 216 | 0.310 |
Why?
|
Flagellin | 1 | 2008 | 18 | 0.310 |
Why?
|
Swine | 6 | 2013 | 582 | 0.310 |
Why?
|
Hyperplasia | 4 | 2020 | 152 | 0.300 |
Why?
|
Bacterial Proteins | 6 | 2018 | 885 | 0.300 |
Why?
|
Ubiquitin-Protein Ligases | 4 | 2012 | 170 | 0.300 |
Why?
|
Permeability | 8 | 2018 | 137 | 0.300 |
Why?
|
Genetic Therapy | 2 | 2013 | 369 | 0.300 |
Why?
|
Cell Differentiation | 6 | 2015 | 1518 | 0.300 |
Why?
|
Escherichia coli | 4 | 2018 | 605 | 0.300 |
Why?
|
Anions | 5 | 2013 | 31 | 0.300 |
Why?
|
Risk Factors | 6 | 2020 | 5449 | 0.300 |
Why?
|
Adult | 18 | 2024 | 26348 | 0.290 |
Why?
|
Adaptor Protein Complex mu Subunits | 1 | 2007 | 3 | 0.290 |
Why?
|
Adaptor Protein Complex 2 | 1 | 2007 | 6 | 0.290 |
Why?
|
Clathrin Heavy Chains | 1 | 2007 | 4 | 0.290 |
Why?
|
Kinetics | 14 | 2007 | 1530 | 0.290 |
Why?
|
Interleukin-6 | 4 | 2022 | 260 | 0.290 |
Why?
|
Immediate-Early Proteins | 1 | 2008 | 166 | 0.290 |
Why?
|
Adenocarcinoma | 2 | 2007 | 1184 | 0.290 |
Why?
|
Mice, Mutant Strains | 5 | 2017 | 231 | 0.290 |
Why?
|
Cell Line, Transformed | 3 | 2010 | 155 | 0.290 |
Why?
|
Genetic Markers | 2 | 2020 | 478 | 0.290 |
Why?
|
Models, Biological | 10 | 2018 | 1764 | 0.290 |
Why?
|
Epithelium | 12 | 2005 | 325 | 0.280 |
Why?
|
T-Lymphocytes | 6 | 2017 | 1221 | 0.280 |
Why?
|
Thrombosis | 2 | 2022 | 301 | 0.280 |
Why?
|
Diabetes Complications | 1 | 2008 | 172 | 0.280 |
Why?
|
Barrett Esophagus | 1 | 2007 | 93 | 0.280 |
Why?
|
Enzyme Activation | 10 | 2015 | 698 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2014 | 340 | 0.280 |
Why?
|
Plasmids | 2 | 2024 | 292 | 0.280 |
Why?
|
Phenols | 2 | 2017 | 41 | 0.280 |
Why?
|
Bacterial Toxins | 3 | 2009 | 114 | 0.280 |
Why?
|
Adhesins, Bacterial | 5 | 2005 | 36 | 0.280 |
Why?
|
Biomarkers | 7 | 2018 | 1759 | 0.270 |
Why?
|
RNA Interference | 4 | 2015 | 378 | 0.270 |
Why?
|
Lectins | 5 | 2005 | 84 | 0.270 |
Why?
|
Calcium Signaling | 1 | 2007 | 138 | 0.270 |
Why?
|
Serpins | 2 | 2017 | 31 | 0.270 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2007 | 156 | 0.270 |
Why?
|
Zonula Occludens-1 Protein | 4 | 2017 | 70 | 0.270 |
Why?
|
Vitis | 2 | 2016 | 19 | 0.270 |
Why?
|
Cell Line, Tumor | 11 | 2020 | 2538 | 0.270 |
Why?
|
Precancerous Conditions | 1 | 2007 | 200 | 0.260 |
Why?
|
Esophagus | 3 | 2019 | 107 | 0.260 |
Why?
|
Animals, Newborn | 8 | 2017 | 523 | 0.260 |
Why?
|
Bariatric Surgery | 2 | 2019 | 195 | 0.260 |
Why?
|
Disease Progression | 4 | 2016 | 1490 | 0.260 |
Why?
|
Rabbits | 14 | 2005 | 640 | 0.260 |
Why?
|
Chromatography, Liquid | 3 | 2016 | 106 | 0.260 |
Why?
|
Hyperoxaluria | 2 | 2023 | 26 | 0.260 |
Why?
|
Vaccinia virus | 1 | 2005 | 19 | 0.260 |
Why?
|
Beclin-1 | 2 | 2015 | 15 | 0.250 |
Why?
|
Cell Membrane | 9 | 2008 | 669 | 0.250 |
Why?
|
Phorbol 12,13-Dibutyrate | 6 | 1999 | 20 | 0.250 |
Why?
|
Anti-Ulcer Agents | 1 | 2005 | 22 | 0.250 |
Why?
|
Sulfasalazine | 1 | 2005 | 34 | 0.250 |
Why?
|
Gastroenteritis | 2 | 2016 | 26 | 0.250 |
Why?
|
Neovascularization, Physiologic | 2 | 2017 | 142 | 0.250 |
Why?
|
Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2004 | 4 | 0.250 |
Why?
|
Genes, Reporter | 5 | 2009 | 275 | 0.250 |
Why?
|
Blotting, Northern | 8 | 2003 | 259 | 0.250 |
Why?
|
Nitroprusside | 2 | 1996 | 32 | 0.250 |
Why?
|
Aging | 3 | 2016 | 712 | 0.250 |
Why?
|
Antineoplastic Agents | 5 | 2012 | 2406 | 0.250 |
Why?
|
Polymerase Chain Reaction | 7 | 2015 | 927 | 0.250 |
Why?
|
Prodrugs | 1 | 2005 | 49 | 0.250 |
Why?
|
Pregnancy | 8 | 2024 | 2996 | 0.250 |
Why?
|
Microglia | 2 | 2024 | 106 | 0.250 |
Why?
|
RNA, Bacterial | 2 | 2017 | 111 | 0.240 |
Why?
|
Macular Degeneration | 2 | 2022 | 61 | 0.240 |
Why?
|
Kidney Cortex | 2 | 1994 | 34 | 0.240 |
Why?
|
Labetalol | 1 | 2024 | 6 | 0.240 |
Why?
|
Nifedipine | 1 | 2024 | 25 | 0.240 |
Why?
|
Esophageal Neoplasms | 1 | 2007 | 329 | 0.240 |
Why?
|
Calpain | 2 | 2015 | 113 | 0.240 |
Why?
|
Hyperthermia, Induced | 1 | 2005 | 73 | 0.240 |
Why?
|
Phenotype | 8 | 2022 | 2435 | 0.240 |
Why?
|
Superantigens | 1 | 2004 | 24 | 0.240 |
Why?
|
Chemokine CCL2 | 4 | 2013 | 47 | 0.240 |
Why?
|
Tetracycline | 1 | 2024 | 13 | 0.240 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 2004 | 32 | 0.240 |
Why?
|
Amyloid beta-Peptides | 2 | 2024 | 204 | 0.230 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2015 | 201 | 0.230 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2015 | 409 | 0.230 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 40 | 0.230 |
Why?
|
Infant, Newborn | 8 | 2024 | 2445 | 0.230 |
Why?
|
Interleukin-2 | 2 | 2003 | 251 | 0.230 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2017 | 217 | 0.230 |
Why?
|
Microtubule-Associated Proteins | 2 | 2015 | 183 | 0.230 |
Why?
|
Dinoprostone | 5 | 1996 | 70 | 0.230 |
Why?
|
Shock, Septic | 2 | 2003 | 104 | 0.230 |
Why?
|
Middle Aged | 15 | 2020 | 25699 | 0.230 |
Why?
|
Prognosis | 4 | 2020 | 3750 | 0.230 |
Why?
|
Cell Membrane Permeability | 5 | 2005 | 120 | 0.230 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 2015 | 147 | 0.230 |
Why?
|
Bile | 2 | 2023 | 57 | 0.220 |
Why?
|
Biological Assay | 1 | 2023 | 79 | 0.220 |
Why?
|
Interleukin-11 | 1 | 2003 | 20 | 0.220 |
Why?
|
Bacteroidetes | 3 | 2024 | 37 | 0.220 |
Why?
|
Neoplasms, Experimental | 1 | 2005 | 269 | 0.220 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2019 | 124 | 0.220 |
Why?
|
Enterobacteriaceae | 1 | 2003 | 21 | 0.220 |
Why?
|
Retina | 2 | 2023 | 214 | 0.220 |
Why?
|
Acclimatization | 1 | 2023 | 76 | 0.220 |
Why?
|
Clonidine | 5 | 2009 | 33 | 0.220 |
Why?
|
Colorectal Surgery | 1 | 2023 | 22 | 0.220 |
Why?
|
Gestational Age | 1 | 2024 | 322 | 0.220 |
Why?
|
Gastrointestinal Agents | 1 | 2005 | 167 | 0.220 |
Why?
|
Safflower Oil | 2 | 2013 | 7 | 0.220 |
Why?
|
Fibroblasts | 8 | 2007 | 755 | 0.220 |
Why?
|
Endotoxins | 3 | 2005 | 36 | 0.220 |
Why?
|
Cluster Analysis | 4 | 2014 | 371 | 0.220 |
Why?
|
Protein Transport | 4 | 2009 | 419 | 0.220 |
Why?
|
Acidosis | 2 | 2002 | 55 | 0.220 |
Why?
|
Loperamide | 2 | 2017 | 7 | 0.220 |
Why?
|
Th1 Cells | 2 | 2015 | 166 | 0.220 |
Why?
|
Cyclic GMP | 4 | 1998 | 59 | 0.220 |
Why?
|
Blood Glucose | 3 | 2016 | 840 | 0.220 |
Why?
|
Diet, Fat-Restricted | 2 | 2013 | 30 | 0.220 |
Why?
|
In Situ Hybridization | 7 | 2011 | 312 | 0.220 |
Why?
|
Glucose Transporter Type 4 | 2 | 2015 | 17 | 0.210 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2017 | 302 | 0.210 |
Why?
|
Mice, Obese | 1 | 2022 | 43 | 0.210 |
Why?
|
Oxidation-Reduction | 4 | 2016 | 385 | 0.210 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 23 | 0.210 |
Why?
|
Bleomycin | 1 | 2022 | 102 | 0.210 |
Why?
|
Renal Insufficiency | 1 | 2023 | 102 | 0.210 |
Why?
|
Inflammasomes | 1 | 2022 | 26 | 0.210 |
Why?
|
Adaptive Immunity | 2 | 2015 | 167 | 0.210 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2015 | 55 | 0.210 |
Why?
|
Virulence | 7 | 2015 | 277 | 0.210 |
Why?
|
Sucrase-Isomaltase Complex | 2 | 1992 | 2 | 0.210 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2023 | 68 | 0.210 |
Why?
|
Human Umbilical Vein Endothelial Cells | 4 | 2015 | 68 | 0.210 |
Why?
|
Cell Culture Techniques | 2 | 2015 | 192 | 0.210 |
Why?
|
Neutrophil Activation | 1 | 2022 | 11 | 0.210 |
Why?
|
Chrysanthemum | 1 | 2021 | 1 | 0.200 |
Why?
|
Peptide Transporter 1 | 3 | 2006 | 3 | 0.200 |
Why?
|
Gastric Mucosa | 2 | 2003 | 66 | 0.200 |
Why?
|
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2019 | 16 | 0.200 |
Why?
|
Endotoxemia | 1 | 2001 | 18 | 0.200 |
Why?
|
Exocytosis | 3 | 2009 | 108 | 0.200 |
Why?
|
Parenteral Nutrition | 2 | 2020 | 64 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinases | 4 | 2008 | 226 | 0.200 |
Why?
|
Oxalobacter formigenes | 2 | 2023 | 5 | 0.200 |
Why?
|
Electric Impedance | 5 | 2006 | 110 | 0.200 |
Why?
|
Leukocytes, Mononuclear | 1 | 2003 | 205 | 0.200 |
Why?
|
Mice, Inbred BALB C | 9 | 2023 | 1086 | 0.200 |
Why?
|
Flowers | 1 | 2021 | 37 | 0.200 |
Why?
|
Acetaminophen | 2 | 2023 | 55 | 0.200 |
Why?
|
Ischemia | 2 | 2017 | 251 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 478 | 0.200 |
Why?
|
Amino Acid Sequence | 8 | 2009 | 2062 | 0.200 |
Why?
|
Diet, Vegetarian | 1 | 2021 | 8 | 0.200 |
Why?
|
Dietary Sugars | 1 | 2021 | 8 | 0.200 |
Why?
|
Anastomosis, Surgical | 4 | 2023 | 274 | 0.200 |
Why?
|
Cardiomegaly | 1 | 2022 | 120 | 0.190 |
Why?
|
Oxalates | 2 | 2023 | 48 | 0.190 |
Why?
|
Adipose Tissue, White | 2 | 2021 | 23 | 0.190 |
Why?
|
Retinal Diseases | 1 | 2022 | 90 | 0.190 |
Why?
|
Rats, Wistar | 6 | 2014 | 302 | 0.190 |
Why?
|
Cytosol | 4 | 2015 | 190 | 0.190 |
Why?
|
Monosaccharide Transport Proteins | 3 | 2004 | 73 | 0.190 |
Why?
|
Occludin | 4 | 2010 | 66 | 0.190 |
Why?
|
Human Development | 1 | 2020 | 7 | 0.190 |
Why?
|
beta Catenin | 3 | 2016 | 266 | 0.190 |
Why?
|
Breast Cancer Lymphedema | 1 | 2020 | 4 | 0.190 |
Why?
|
Treatment Outcome | 8 | 2019 | 8178 | 0.190 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 118 | 0.190 |
Why?
|
Environmental Health | 1 | 2020 | 7 | 0.190 |
Why?
|
Metadata | 1 | 2020 | 1 | 0.190 |
Why?
|
Digestive System Diseases | 1 | 2020 | 18 | 0.190 |
Why?
|
Immunoconjugates | 1 | 2021 | 109 | 0.190 |
Why?
|
Sequence Analysis, RNA | 2 | 2021 | 230 | 0.190 |
Why?
|
Cefoperazone | 1 | 2020 | 1 | 0.190 |
Why?
|
Mass Screening | 1 | 2005 | 631 | 0.190 |
Why?
|
Health | 1 | 2020 | 29 | 0.190 |
Why?
|
Stem Cells | 2 | 2021 | 371 | 0.190 |
Why?
|
Genetic Variation | 2 | 2018 | 1369 | 0.190 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 379 | 0.190 |
Why?
|
Butyric Acid | 1 | 2020 | 11 | 0.190 |
Why?
|
Exosomes | 2 | 2019 | 53 | 0.190 |
Why?
|
Immune System Diseases | 1 | 2020 | 26 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2011 | 447 | 0.180 |
Why?
|
Biological Clocks | 1 | 2021 | 74 | 0.180 |
Why?
|
In Vitro Techniques | 11 | 2014 | 995 | 0.180 |
Why?
|
Neutrophils | 1 | 2022 | 308 | 0.180 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2020 | 11 | 0.180 |
Why?
|
Chloride-Bicarbonate Antiporters | 2 | 2011 | 9 | 0.180 |
Why?
|
CD47 Antigen | 1 | 2020 | 23 | 0.180 |
Why?
|
Bifidobacterium | 2 | 2020 | 16 | 0.180 |
Why?
|
Femoral Artery | 1 | 2020 | 83 | 0.180 |
Why?
|
Nanoparticles | 1 | 2021 | 163 | 0.180 |
Why?
|
Vascular System Injuries | 1 | 2020 | 28 | 0.180 |
Why?
|
Regeneration | 1 | 2021 | 150 | 0.180 |
Why?
|
Antibodies, Viral | 1 | 2021 | 306 | 0.180 |
Why?
|
Cell Adhesion | 3 | 2017 | 425 | 0.180 |
Why?
|
Specimen Handling | 1 | 2020 | 101 | 0.180 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 223 | 0.180 |
Why?
|
Drug Resistance, Bacterial | 1 | 2020 | 75 | 0.180 |
Why?
|
Critical Illness | 6 | 2017 | 304 | 0.170 |
Why?
|
Metabolome | 1 | 2020 | 49 | 0.170 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 58 | 0.170 |
Why?
|
Kidney Calculi | 1 | 2023 | 340 | 0.170 |
Why?
|
PPAR gamma | 2 | 2017 | 74 | 0.170 |
Why?
|
Adoptive Transfer | 2 | 2017 | 169 | 0.170 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2019 | 47 | 0.170 |
Why?
|
Kinesiology, Applied | 1 | 2019 | 1 | 0.170 |
Why?
|
Mouth | 1 | 2019 | 48 | 0.170 |
Why?
|
Immunoblotting | 7 | 2006 | 274 | 0.170 |
Why?
|
Kidney | 6 | 2006 | 1145 | 0.170 |
Why?
|
Receptors, Adrenergic, alpha | 3 | 1985 | 16 | 0.170 |
Why?
|
Genetic Heterogeneity | 1 | 2019 | 62 | 0.170 |
Why?
|
Young Adult | 5 | 2024 | 6218 | 0.170 |
Why?
|
Angioplasty, Balloon | 1 | 2020 | 96 | 0.170 |
Why?
|
Lymphedema | 1 | 2020 | 77 | 0.170 |
Why?
|
Fagopyrum | 1 | 2019 | 1 | 0.170 |
Why?
|
Solute Carrier Family 22 Member 5 | 2 | 2010 | 5 | 0.170 |
Why?
|
Public Opinion | 1 | 2019 | 42 | 0.170 |
Why?
|
Nitric Oxide | 2 | 2019 | 279 | 0.170 |
Why?
|
Mass Media | 1 | 2019 | 26 | 0.170 |
Why?
|
Protein Processing, Post-Translational | 2 | 2013 | 380 | 0.170 |
Why?
|
Malnutrition | 1 | 2019 | 34 | 0.170 |
Why?
|
Antibodies, Monoclonal | 3 | 2015 | 1402 | 0.170 |
Why?
|
Bacterial Adhesion | 4 | 2009 | 84 | 0.170 |
Why?
|
Carcinogenesis | 2 | 2019 | 207 | 0.170 |
Why?
|
Colonic Diseases | 1 | 2019 | 61 | 0.170 |
Why?
|
Arteritis | 1 | 2018 | 9 | 0.170 |
Why?
|
Food | 1 | 2019 | 86 | 0.160 |
Why?
|
Health Plan Implementation | 1 | 2019 | 56 | 0.160 |
Why?
|
Vasculitis | 2 | 2016 | 39 | 0.160 |
Why?
|
Exercise Test | 1 | 2020 | 165 | 0.160 |
Why?
|
Lymph Node Excision | 1 | 2020 | 221 | 0.160 |
Why?
|
Polyethylene Glycols | 3 | 2021 | 365 | 0.160 |
Why?
|
Selenium | 2 | 2017 | 46 | 0.160 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 85 | 0.160 |
Why?
|
NAD | 2 | 2015 | 68 | 0.160 |
Why?
|
Organoids | 2 | 2019 | 62 | 0.160 |
Why?
|
Organ Specificity | 3 | 2018 | 272 | 0.160 |
Why?
|
Heat Shock Transcription Factors | 2 | 2011 | 9 | 0.160 |
Why?
|
Aged | 8 | 2020 | 18932 | 0.160 |
Why?
|
Recombinant Proteins | 8 | 2006 | 1020 | 0.160 |
Why?
|
DNA Primers | 3 | 2015 | 543 | 0.160 |
Why?
|
Random Allocation | 2 | 2012 | 329 | 0.160 |
Why?
|
Vasodilation | 2 | 2017 | 94 | 0.160 |
Why?
|
Leukocyte Common Antigens | 2 | 2017 | 46 | 0.160 |
Why?
|
Sex Factors | 2 | 2021 | 1063 | 0.160 |
Why?
|
Weight Gain | 3 | 2014 | 122 | 0.160 |
Why?
|
Colectomy | 1 | 2019 | 169 | 0.160 |
Why?
|
DNA, Ribosomal | 3 | 2018 | 46 | 0.160 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 2015 | 77 | 0.160 |
Why?
|
Homeodomain Proteins | 3 | 2010 | 554 | 0.160 |
Why?
|
Sirtuins | 2 | 2017 | 46 | 0.160 |
Why?
|
Membrane Fluidity | 1 | 1997 | 8 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2018 | 44 | 0.150 |
Why?
|
Pelvic Exenteration | 1 | 2017 | 5 | 0.150 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2017 | 16 | 0.150 |
Why?
|
Research | 1 | 2019 | 251 | 0.150 |
Why?
|
Trans-Activators | 3 | 2005 | 443 | 0.150 |
Why?
|
Nutritional Status | 2 | 2018 | 84 | 0.150 |
Why?
|
Liver Diseases | 1 | 2020 | 250 | 0.150 |
Why?
|
Membrane Glycoproteins | 5 | 2009 | 431 | 0.150 |
Why?
|
Kidney Medulla | 2 | 1994 | 80 | 0.150 |
Why?
|
Reference Values | 4 | 2012 | 665 | 0.150 |
Why?
|
Mass Spectrometry | 2 | 2016 | 193 | 0.150 |
Why?
|
Fructose | 1 | 2017 | 36 | 0.150 |
Why?
|
Shear Strength | 1 | 2017 | 18 | 0.150 |
Why?
|
DNA, Antisense | 3 | 2003 | 15 | 0.150 |
Why?
|
Gene Knockdown Techniques | 2 | 2015 | 247 | 0.150 |
Why?
|
Kidney Tubules, Proximal | 2 | 1995 | 60 | 0.150 |
Why?
|
Peripartum Period | 1 | 2017 | 29 | 0.150 |
Why?
|
Adipokines | 2 | 2016 | 19 | 0.150 |
Why?
|
Cytoskeletal Proteins | 4 | 2005 | 227 | 0.150 |
Why?
|
Lipids | 2 | 2016 | 272 | 0.140 |
Why?
|
Immunoglobulins | 1 | 2017 | 148 | 0.140 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2016 | 13 | 0.140 |
Why?
|
Ileitis | 1 | 2016 | 7 | 0.140 |
Why?
|
Immunotherapy | 2 | 2020 | 661 | 0.140 |
Why?
|
Medicine, Traditional | 1 | 2016 | 8 | 0.140 |
Why?
|
RNA, Transfer | 1 | 2018 | 159 | 0.140 |
Why?
|
History, 21st Century | 2 | 2014 | 177 | 0.140 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2017 | 144 | 0.140 |
Why?
|
Biological Factors | 1 | 2016 | 18 | 0.140 |
Why?
|
Gene-Environment Interaction | 2 | 2015 | 109 | 0.140 |
Why?
|
Bifidobacterium breve | 1 | 2016 | 2 | 0.140 |
Why?
|
Receptors, Pattern Recognition | 1 | 2016 | 19 | 0.140 |
Why?
|
Blood Coagulation | 1 | 2017 | 92 | 0.140 |
Why?
|
Streptomycin | 1 | 2016 | 5 | 0.140 |
Why?
|
Autophagy-Related Protein 7 | 1 | 2016 | 12 | 0.140 |
Why?
|
Ubiquitin | 2 | 2009 | 97 | 0.140 |
Why?
|
Interleukin-1 | 2 | 2001 | 71 | 0.140 |
Why?
|
Penicillins | 1 | 2016 | 20 | 0.140 |
Why?
|
Carotid Stenosis | 1 | 2017 | 115 | 0.140 |
Why?
|
Regional Blood Flow | 3 | 2015 | 198 | 0.140 |
Why?
|
Saponins | 1 | 2016 | 42 | 0.140 |
Why?
|
Prostatic Neoplasms | 3 | 2007 | 1764 | 0.140 |
Why?
|
Peripheral Arterial Disease | 1 | 2017 | 92 | 0.140 |
Why?
|
Vascular Surgical Procedures | 1 | 2017 | 149 | 0.140 |
Why?
|
Luciferases | 2 | 2008 | 128 | 0.140 |
Why?
|
Research Design | 2 | 2018 | 594 | 0.140 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 115 | 0.140 |
Why?
|
Cellular Senescence | 1 | 2017 | 103 | 0.140 |
Why?
|
Child | 3 | 2022 | 7089 | 0.140 |
Why?
|
Promoter Regions, Genetic | 3 | 2013 | 956 | 0.140 |
Why?
|
Mast Cells | 1 | 2016 | 93 | 0.140 |
Why?
|
Fats | 1 | 2016 | 12 | 0.140 |
Why?
|
Celiac Disease | 1 | 2019 | 210 | 0.140 |
Why?
|
Polyphenols | 1 | 2016 | 13 | 0.140 |
Why?
|
Lymphocyte Activation | 5 | 2015 | 747 | 0.140 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 2 | 2013 | 12 | 0.140 |
Why?
|
Yersinia Infections | 1 | 2016 | 5 | 0.140 |
Why?
|
Kidney Transplantation | 1 | 2023 | 853 | 0.140 |
Why?
|
Ileus | 2 | 2013 | 9 | 0.140 |
Why?
|
SUMO-1 Protein | 2 | 2013 | 16 | 0.140 |
Why?
|
RNA | 2 | 2022 | 575 | 0.140 |
Why?
|
Immunity | 2 | 2015 | 140 | 0.130 |
Why?
|
Plant Preparations | 1 | 2016 | 20 | 0.130 |
Why?
|
Leukocytes | 1 | 2017 | 203 | 0.130 |
Why?
|
Bethanechol Compounds | 2 | 1992 | 2 | 0.130 |
Why?
|
Deoxyribonuclease I | 1 | 2015 | 28 | 0.130 |
Why?
|
Yersinia enterocolitica | 1 | 2016 | 18 | 0.130 |
Why?
|
Contig Mapping | 1 | 2015 | 5 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2015 | 4 | 0.130 |
Why?
|
Rutin | 1 | 2015 | 2 | 0.130 |
Why?
|
Interleukin-1alpha | 1 | 2015 | 4 | 0.130 |
Why?
|
Leukemia | 1 | 2018 | 321 | 0.130 |
Why?
|
Cricetinae | 4 | 1997 | 560 | 0.130 |
Why?
|
Butter | 1 | 2015 | 2 | 0.130 |
Why?
|
Indoles | 1 | 2017 | 310 | 0.130 |
Why?
|
Dietary Sucrose | 1 | 2015 | 13 | 0.130 |
Why?
|
Animals, Genetically Modified | 2 | 2013 | 182 | 0.130 |
Why?
|
Postoperative Complications | 4 | 2022 | 2285 | 0.130 |
Why?
|
Rats, Inbred OLETF | 1 | 2015 | 2 | 0.130 |
Why?
|
Lipogenesis | 1 | 2015 | 24 | 0.130 |
Why?
|
Anti-Obesity Agents | 1 | 2015 | 12 | 0.130 |
Why?
|
Genome, Bacterial | 1 | 2016 | 145 | 0.130 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2024 | 157 | 0.130 |
Why?
|
Nitric Oxide Synthase | 1 | 1996 | 126 | 0.130 |
Why?
|
Adenosine Triphosphate | 3 | 2014 | 315 | 0.130 |
Why?
|
Macrolides | 1 | 2015 | 31 | 0.130 |
Why?
|
Mucin-2 | 1 | 2015 | 12 | 0.130 |
Why?
|
Tandem Mass Spectrometry | 2 | 2017 | 105 | 0.130 |
Why?
|
Lubiprostone | 2 | 2013 | 3 | 0.130 |
Why?
|
Incidence | 2 | 2012 | 1592 | 0.130 |
Why?
|
Firmicutes | 1 | 2015 | 15 | 0.130 |
Why?
|
Microscopy, Confocal | 2 | 2007 | 275 | 0.130 |
Why?
|
Palmitic Acid | 1 | 2015 | 28 | 0.130 |
Why?
|
Sleep Deprivation | 1 | 2016 | 137 | 0.130 |
Why?
|
Dendritic Cells | 3 | 2020 | 436 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 1996 | 146 | 0.130 |
Why?
|
Wnt Signaling Pathway | 1 | 2016 | 97 | 0.130 |
Why?
|
Pancreas | 2 | 2013 | 242 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2023 | 421 | 0.130 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2015 | 90 | 0.130 |
Why?
|
Medical Oncology | 1 | 2019 | 376 | 0.130 |
Why?
|
Fascia | 1 | 2015 | 30 | 0.130 |
Why?
|
Enterocolitis, Necrotizing | 3 | 2013 | 79 | 0.130 |
Why?
|
Biopsy | 2 | 2010 | 1187 | 0.130 |
Why?
|
Caspases | 3 | 2012 | 156 | 0.130 |
Why?
|
Caenorhabditis elegans | 1 | 2017 | 229 | 0.120 |
Why?
|
Amelogenesis | 2 | 2012 | 2 | 0.120 |
Why?
|
SLC4A Proteins | 2 | 2012 | 2 | 0.120 |
Why?
|
Biological Transport, Active | 5 | 2008 | 102 | 0.120 |
Why?
|
Dipeptides | 1 | 2015 | 42 | 0.120 |
Why?
|
Species Specificity | 2 | 2015 | 685 | 0.120 |
Why?
|
Immunoprecipitation | 3 | 2014 | 139 | 0.120 |
Why?
|
Viscosity | 1 | 2014 | 46 | 0.120 |
Why?
|
Cysteine Endopeptidases | 1 | 2015 | 88 | 0.120 |
Why?
|
Anion Transport Proteins | 2 | 2012 | 10 | 0.120 |
Why?
|
Cell Cycle Checkpoints | 1 | 2015 | 64 | 0.120 |
Why?
|
Water-Electrolyte Balance | 2 | 1992 | 67 | 0.120 |
Why?
|
Mitogens | 2 | 2005 | 63 | 0.120 |
Why?
|
Real-Time Polymerase Chain Reaction | 4 | 2019 | 282 | 0.120 |
Why?
|
Precipitin Tests | 3 | 2004 | 111 | 0.120 |
Why?
|
Thiazoles | 1 | 2015 | 128 | 0.120 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 38 | 0.120 |
Why?
|
Environment | 1 | 2016 | 224 | 0.120 |
Why?
|
Antidiarrheals | 2 | 2001 | 14 | 0.120 |
Why?
|
Enteritis | 1 | 2014 | 21 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2014 | 71 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 77 | 0.120 |
Why?
|
Physical Conditioning, Animal | 1 | 2014 | 19 | 0.120 |
Why?
|
Gene Targeting | 1 | 2014 | 73 | 0.120 |
Why?
|
Environmental Exposure | 1 | 2017 | 321 | 0.120 |
Why?
|
Thiazolidinediones | 1 | 2014 | 74 | 0.120 |
Why?
|
Binding Sites | 3 | 2012 | 1113 | 0.120 |
Why?
|
Famous Persons | 1 | 2014 | 8 | 0.120 |
Why?
|
Immunization | 1 | 2014 | 160 | 0.120 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2015 | 120 | 0.120 |
Why?
|
High Mobility Group Proteins | 1 | 2013 | 26 | 0.120 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2014 | 45 | 0.120 |
Why?
|
Potassium | 2 | 2001 | 253 | 0.120 |
Why?
|
Airway Remodeling | 1 | 2013 | 9 | 0.120 |
Why?
|
Nitric Oxide Synthase Type III | 4 | 2017 | 89 | 0.120 |
Why?
|
Cell Polarity | 2 | 2009 | 116 | 0.120 |
Why?
|
Flavonoids | 1 | 2014 | 87 | 0.120 |
Why?
|
Brain | 2 | 2021 | 2268 | 0.110 |
Why?
|
DNA | 4 | 2004 | 1308 | 0.110 |
Why?
|
Adenomatous Polyps | 1 | 2013 | 12 | 0.110 |
Why?
|
Nucleosomes | 1 | 2013 | 55 | 0.110 |
Why?
|
Glucose Transporter Type 1 | 2 | 2009 | 20 | 0.110 |
Why?
|
Thapsigargin | 2 | 2007 | 55 | 0.110 |
Why?
|
Electrophysiological Phenomena | 1 | 2013 | 50 | 0.110 |
Why?
|
Carrageenan | 1 | 2013 | 9 | 0.110 |
Why?
|
B7-H1 Antigen | 1 | 2015 | 270 | 0.110 |
Why?
|
Severity of Illness Index | 3 | 2020 | 1843 | 0.110 |
Why?
|
Food Hypersensitivity | 1 | 2014 | 67 | 0.110 |
Why?
|
Gonads | 1 | 2013 | 19 | 0.110 |
Why?
|
Immune System | 1 | 2014 | 97 | 0.110 |
Why?
|
Allergens | 1 | 2014 | 181 | 0.110 |
Why?
|
Immunoenzyme Techniques | 2 | 2010 | 306 | 0.110 |
Why?
|
Receptors, Calcitriol | 1 | 2014 | 129 | 0.110 |
Why?
|
Pancreatitis | 1 | 2013 | 86 | 0.110 |
Why?
|
Sodium Chloride | 1 | 1993 | 87 | 0.110 |
Why?
|
Mesentery | 1 | 2013 | 45 | 0.110 |
Why?
|
Mice, Inbred CFTR | 1 | 2013 | 4 | 0.110 |
Why?
|
History, 20th Century | 1 | 2014 | 307 | 0.110 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2014 | 89 | 0.110 |
Why?
|
Hemorheology | 1 | 2013 | 8 | 0.110 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2012 | 5 | 0.110 |
Why?
|
Hippocampus | 1 | 1996 | 446 | 0.110 |
Why?
|
RNA-Binding Proteins | 2 | 2018 | 258 | 0.110 |
Why?
|
Surgical Wound Infection | 1 | 2015 | 199 | 0.110 |
Why?
|
Response Elements | 2 | 2011 | 65 | 0.110 |
Why?
|
Muscle, Smooth | 2 | 1991 | 354 | 0.110 |
Why?
|
Reperfusion Injury | 1 | 2014 | 139 | 0.110 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2024 | 74 | 0.110 |
Why?
|
Receptors, Adrenergic | 2 | 1983 | 15 | 0.110 |
Why?
|
Lymphotoxin beta Receptor | 1 | 2012 | 29 | 0.110 |
Why?
|
Rats, Inbred Strains | 6 | 1992 | 312 | 0.110 |
Why?
|
Sucrase | 1 | 1992 | 2 | 0.110 |
Why?
|
Monocytes | 1 | 2014 | 217 | 0.110 |
Why?
|
Lactobacillus | 2 | 2018 | 21 | 0.110 |
Why?
|
Retinal Pigment Epithelium | 2 | 2022 | 12 | 0.110 |
Why?
|
Androgen Receptor Antagonists | 2 | 2002 | 22 | 0.110 |
Why?
|
Taurine | 1 | 2012 | 11 | 0.110 |
Why?
|
GTP-Binding Proteins | 1 | 1993 | 147 | 0.110 |
Why?
|
Transduction, Genetic | 1 | 2013 | 160 | 0.110 |
Why?
|
Receptors, Oxytocin | 1 | 2012 | 10 | 0.110 |
Why?
|
Lymphotoxin-alpha | 1 | 2012 | 44 | 0.110 |
Why?
|
Transgenes | 1 | 2013 | 185 | 0.110 |
Why?
|
Retrospective Studies | 6 | 2022 | 8893 | 0.110 |
Why?
|
Uterine Contraction | 1 | 2012 | 9 | 0.110 |
Why?
|
Gene Transfer Techniques | 1 | 2013 | 153 | 0.110 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2017 | 43 | 0.110 |
Why?
|
Molecular Weight | 5 | 2009 | 332 | 0.110 |
Why?
|
3T3 Cells | 2 | 2003 | 97 | 0.110 |
Why?
|
Sodium Radioisotopes | 2 | 2009 | 2 | 0.110 |
Why?
|
Choroid | 2 | 2022 | 35 | 0.100 |
Why?
|
Body Composition | 2 | 2012 | 70 | 0.100 |
Why?
|
Caspase 9 | 2 | 2002 | 49 | 0.100 |
Why?
|
Sulfites | 1 | 2012 | 30 | 0.100 |
Why?
|
CD3 Complex | 4 | 2014 | 134 | 0.100 |
Why?
|
Ovariectomy | 1 | 2012 | 81 | 0.100 |
Why?
|
Heart Failure | 1 | 2022 | 1171 | 0.100 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 450 | 0.100 |
Why?
|
Sigmoidoscopy | 1 | 2012 | 36 | 0.100 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 99 | 0.100 |
Why?
|
Androgen Antagonists | 2 | 2003 | 154 | 0.100 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 309 | 0.100 |
Why?
|
Ion Channels | 2 | 1991 | 246 | 0.100 |
Why?
|
Organogenesis | 1 | 2012 | 50 | 0.100 |
Why?
|
Metabolic Syndrome | 1 | 2013 | 130 | 0.100 |
Why?
|
Immunomodulation | 1 | 2012 | 56 | 0.100 |
Why?
|
Connexin 43 | 1 | 2012 | 94 | 0.100 |
Why?
|
Antigens, Bacterial | 1 | 2012 | 135 | 0.100 |
Why?
|
Myocytes, Cardiac | 2 | 2012 | 312 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 2 | 2009 | 43 | 0.100 |
Why?
|
Arthritis, Rheumatoid | 1 | 2013 | 167 | 0.100 |
Why?
|
Biopsy, Needle | 1 | 2012 | 235 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 348 | 0.100 |
Why?
|
Pectins | 2 | 2001 | 5 | 0.100 |
Why?
|
Visual Acuity | 2 | 2023 | 198 | 0.100 |
Why?
|
Pesticide Residues | 1 | 2011 | 2 | 0.100 |
Why?
|
Lymphocytes | 2 | 2004 | 470 | 0.100 |
Why?
|
Solid Phase Extraction | 1 | 2011 | 13 | 0.100 |
Why?
|
Eflornithine | 1 | 2011 | 13 | 0.100 |
Why?
|
Calcification, Physiologic | 1 | 2011 | 33 | 0.100 |
Why?
|
Melanoma | 1 | 2015 | 463 | 0.100 |
Why?
|
Food Contamination | 1 | 2011 | 32 | 0.100 |
Why?
|
Rats, Inbred Lew | 5 | 2020 | 193 | 0.100 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 311 | 0.100 |
Why?
|
Proto-Oncogenes | 1 | 2011 | 61 | 0.100 |
Why?
|
Genome | 1 | 2014 | 385 | 0.100 |
Why?
|
Dissection | 1 | 2011 | 43 | 0.100 |
Why?
|
Vegetables | 1 | 2011 | 46 | 0.100 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2011 | 42 | 0.100 |
Why?
|
Arachidonate Lipoxygenases | 1 | 1990 | 1 | 0.090 |
Why?
|
Hydrogen | 2 | 1988 | 47 | 0.090 |
Why?
|
Plaque, Amyloid | 2 | 2024 | 56 | 0.090 |
Why?
|
Fruit | 1 | 2011 | 75 | 0.090 |
Why?
|
Light | 2 | 2022 | 292 | 0.090 |
Why?
|
Collagen | 2 | 2019 | 296 | 0.090 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 1990 | 22 | 0.090 |
Why?
|
Software | 1 | 2015 | 663 | 0.090 |
Why?
|
Administration, Oral | 3 | 2024 | 684 | 0.090 |
Why?
|
Atrial Natriuretic Factor | 1 | 1990 | 39 | 0.090 |
Why?
|
Organ Size | 3 | 2020 | 369 | 0.090 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2010 | 40 | 0.090 |
Why?
|
Tissue Distribution | 3 | 2010 | 292 | 0.090 |
Why?
|
Interleukin-3 | 1 | 1990 | 36 | 0.090 |
Why?
|
Uterus | 1 | 2012 | 221 | 0.090 |
Why?
|
Clostridium | 2 | 2024 | 23 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2015 | 577 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2013 | 440 | 0.090 |
Why?
|
Antibodies | 2 | 2021 | 354 | 0.090 |
Why?
|
Human Experimentation | 1 | 2010 | 39 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2013 | 419 | 0.090 |
Why?
|
Arachidonic Acids | 1 | 1990 | 41 | 0.090 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 1709 | 0.090 |
Why?
|
Cholesterol | 2 | 2009 | 355 | 0.090 |
Why?
|
Water | 2 | 2006 | 284 | 0.090 |
Why?
|
Galvanic Skin Response | 1 | 2010 | 12 | 0.090 |
Why?
|
T-Cell Intracellular Antigen-1 | 1 | 2010 | 6 | 0.090 |
Why?
|
Parietal Cells, Gastric | 1 | 1990 | 1 | 0.090 |
Why?
|
Gastric Acid | 1 | 1990 | 5 | 0.090 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2010 | 17 | 0.090 |
Why?
|
Claudin-1 | 1 | 2010 | 17 | 0.090 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2010 | 17 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 2 | 2013 | 324 | 0.090 |
Why?
|
Phosphatidylinositols | 1 | 1990 | 21 | 0.090 |
Why?
|
Transforming Growth Factors | 1 | 1989 | 12 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 2 | 2023 | 315 | 0.090 |
Why?
|
Ribonucleoproteins | 1 | 2010 | 38 | 0.090 |
Why?
|
Cytoskeleton | 2 | 2003 | 194 | 0.090 |
Why?
|
Absorption | 3 | 1998 | 25 | 0.090 |
Why?
|
Salmonella | 1 | 1989 | 14 | 0.090 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 20 | 0.090 |
Why?
|
eIF-2 Kinase | 1 | 2010 | 48 | 0.090 |
Why?
|
Interleukins | 3 | 2016 | 136 | 0.090 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2009 | 73 | 0.090 |
Why?
|
Vasoactive Intestinal Peptide | 2 | 1992 | 15 | 0.090 |
Why?
|
Receptors, Adrenergic, alpha-2 | 1 | 2009 | 9 | 0.090 |
Why?
|
Radiation Injuries, Experimental | 1 | 2009 | 41 | 0.090 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2009 | 49 | 0.090 |
Why?
|
Membrane Microdomains | 1 | 2009 | 54 | 0.090 |
Why?
|
Methylation | 2 | 2022 | 267 | 0.090 |
Why?
|
Phosphoserine | 1 | 2009 | 9 | 0.090 |
Why?
|
ras Proteins | 1 | 1990 | 130 | 0.080 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 95 | 0.080 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2009 | 21 | 0.080 |
Why?
|
Intestinal Secretions | 1 | 1989 | 1 | 0.080 |
Why?
|
Losartan | 1 | 2009 | 29 | 0.080 |
Why?
|
Neurotransmitter Agents | 1 | 1990 | 107 | 0.080 |
Why?
|
Cholera Toxin | 1 | 1989 | 21 | 0.080 |
Why?
|
Curcumin | 2 | 2014 | 17 | 0.080 |
Why?
|
Dogs | 5 | 2005 | 704 | 0.080 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2012 | 213 | 0.080 |
Why?
|
Radiation-Protective Agents | 1 | 2009 | 98 | 0.080 |
Why?
|
Receptor, Insulin | 1 | 2009 | 54 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 283 | 0.080 |
Why?
|
Niflumic Acid | 1 | 2008 | 1 | 0.080 |
Why?
|
Methazolamide | 1 | 2008 | 3 | 0.080 |
Why?
|
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2008 | 17 | 0.080 |
Why?
|
Perforin | 1 | 2009 | 55 | 0.080 |
Why?
|
Phorbol Esters | 2 | 1985 | 22 | 0.080 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1999 | 137 | 0.080 |
Why?
|
Clathrin | 1 | 2008 | 29 | 0.080 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2008 | 29 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2016 | 2746 | 0.080 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2008 | 10 | 0.080 |
Why?
|
Milk Proteins | 1 | 2008 | 24 | 0.080 |
Why?
|
Pancreatic Neoplasms | 2 | 2005 | 659 | 0.080 |
Why?
|
Neuroprotective Agents | 1 | 2009 | 96 | 0.080 |
Why?
|
Bronchi | 1 | 2010 | 229 | 0.080 |
Why?
|
Calmodulin | 1 | 1989 | 50 | 0.080 |
Why?
|
Proteins | 3 | 2008 | 786 | 0.080 |
Why?
|
Calcium, Dietary | 1 | 2008 | 64 | 0.080 |
Why?
|
United States | 2 | 2014 | 6882 | 0.080 |
Why?
|
Staphylococcus aureus | 2 | 2018 | 274 | 0.080 |
Why?
|
Isomerism | 3 | 1999 | 29 | 0.080 |
Why?
|
Bacillus anthracis | 1 | 2009 | 73 | 0.080 |
Why?
|
Guanidines | 2 | 1998 | 31 | 0.080 |
Why?
|
Myocardial Infarction | 1 | 2012 | 373 | 0.080 |
Why?
|
Somatostatin | 1 | 1988 | 55 | 0.080 |
Why?
|
ErbB Receptors | 1 | 2011 | 496 | 0.080 |
Why?
|
Cell Size | 2 | 2001 | 68 | 0.080 |
Why?
|
Peptides | 4 | 2023 | 646 | 0.080 |
Why?
|
Sulfones | 2 | 1998 | 45 | 0.080 |
Why?
|
Hydrolases | 2 | 2002 | 30 | 0.080 |
Why?
|
Glycosylation | 4 | 2002 | 129 | 0.080 |
Why?
|
Dactinomycin | 1 | 2008 | 36 | 0.080 |
Why?
|
DNA, Mitochondrial | 2 | 2021 | 187 | 0.080 |
Why?
|
Membrane Potentials | 3 | 2001 | 436 | 0.080 |
Why?
|
Toll-Like Receptor 5 | 1 | 2008 | 10 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2008 | 96 | 0.080 |
Why?
|
Benzimidazoles | 1 | 1989 | 113 | 0.080 |
Why?
|
Gastroparesis | 1 | 2008 | 14 | 0.080 |
Why?
|
Weight Loss | 2 | 2022 | 225 | 0.080 |
Why?
|
Cell Nucleus | 2 | 2005 | 594 | 0.080 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2005 | 78 | 0.080 |
Why?
|
Shock | 1 | 2007 | 44 | 0.080 |
Why?
|
Spores, Bacterial | 1 | 2007 | 18 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2008 | 185 | 0.070 |
Why?
|
Substance Withdrawal Syndrome | 2 | 1985 | 46 | 0.070 |
Why?
|
Dynorphins | 1 | 2007 | 14 | 0.070 |
Why?
|
Calcium-Transporting ATPases | 1 | 2007 | 29 | 0.070 |
Why?
|
Solubility | 2 | 2009 | 178 | 0.070 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 3 | 1992 | 13 | 0.070 |
Why?
|
Receptors, Formyl Peptide | 1 | 2006 | 5 | 0.070 |
Why?
|
Brain Injuries | 1 | 2009 | 163 | 0.070 |
Why?
|
Syndrome | 1 | 2007 | 448 | 0.070 |
Why?
|
Piroxicam | 3 | 1991 | 11 | 0.070 |
Why?
|
Gastric Outlet Obstruction | 1 | 2006 | 10 | 0.070 |
Why?
|
Chinchilla | 1 | 1986 | 4 | 0.070 |
Why?
|
Gastroplasty | 1 | 2006 | 24 | 0.070 |
Why?
|
Cricetulus | 2 | 1997 | 126 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 1988 | 245 | 0.070 |
Why?
|
Infant | 3 | 2024 | 3117 | 0.070 |
Why?
|
Yohimbine | 2 | 1983 | 7 | 0.070 |
Why?
|
Hepatectomy | 3 | 2003 | 172 | 0.070 |
Why?
|
Electric Conductivity | 3 | 1992 | 144 | 0.070 |
Why?
|
Adolescent | 2 | 2016 | 9157 | 0.070 |
Why?
|
Parenteral Nutrition, Total | 1 | 2006 | 41 | 0.070 |
Why?
|
Mammals | 2 | 2022 | 235 | 0.070 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 108 | 0.070 |
Why?
|
Binding, Competitive | 4 | 2012 | 146 | 0.070 |
Why?
|
Phorbols | 1 | 1985 | 9 | 0.070 |
Why?
|
Aminoquinolines | 2 | 2001 | 17 | 0.070 |
Why?
|
Esophagogastric Junction | 1 | 2006 | 34 | 0.070 |
Why?
|
Hemorrhage | 1 | 2007 | 276 | 0.070 |
Why?
|
Short Bowel Syndrome | 1 | 2006 | 41 | 0.070 |
Why?
|
Porins | 1 | 2005 | 21 | 0.070 |
Why?
|
I-kappa B Proteins | 2 | 2005 | 54 | 0.070 |
Why?
|
Topoisomerase II Inhibitors | 1 | 2005 | 27 | 0.070 |
Why?
|
Esophagostomy | 1 | 2005 | 1 | 0.060 |
Why?
|
Oligopeptides | 1 | 2006 | 191 | 0.060 |
Why?
|
Gastric Fundus | 1 | 2005 | 7 | 0.060 |
Why?
|
Intestinal Neoplasms | 1 | 2006 | 57 | 0.060 |
Why?
|
Receptors, CXCR4 | 1 | 2005 | 45 | 0.060 |
Why?
|
Phenylhydrazines | 1 | 2005 | 10 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2008 | 237 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 156 | 0.060 |
Why?
|
Carcinogens | 1 | 1985 | 110 | 0.060 |
Why?
|
Venous Thromboembolism | 1 | 2008 | 158 | 0.060 |
Why?
|
Fundoplication | 1 | 2006 | 78 | 0.060 |
Why?
|
Trachea | 2 | 2019 | 291 | 0.060 |
Why?
|
Endosonography | 1 | 2006 | 98 | 0.060 |
Why?
|
Piperidines | 1 | 1986 | 163 | 0.060 |
Why?
|
Gastrointestinal Contents | 1 | 2004 | 5 | 0.060 |
Why?
|
RNA Precursors | 1 | 2005 | 71 | 0.060 |
Why?
|
Fermentation | 1 | 2004 | 13 | 0.060 |
Why?
|
Gastrectomy | 1 | 2005 | 68 | 0.060 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2004 | 53 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2008 | 344 | 0.060 |
Why?
|
Gastrostomy | 1 | 2005 | 69 | 0.060 |
Why?
|
Risk Assessment | 1 | 2012 | 2286 | 0.060 |
Why?
|
Infant, Small for Gestational Age | 1 | 2024 | 29 | 0.060 |
Why?
|
Branchio-Oto-Renal Syndrome | 1 | 2004 | 4 | 0.060 |
Why?
|
Camptothecin | 1 | 2005 | 191 | 0.060 |
Why?
|
Prospective Studies | 3 | 2017 | 4271 | 0.060 |
Why?
|
Bradykinin | 2 | 1996 | 46 | 0.060 |
Why?
|
Mannitol | 3 | 2001 | 50 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2017 | 1851 | 0.060 |
Why?
|
Amyloidogenic Proteins | 1 | 2024 | 14 | 0.060 |
Why?
|
Tetramethylphenylenediamine | 1 | 2004 | 1 | 0.060 |
Why?
|
Cimetidine | 1 | 2004 | 7 | 0.060 |
Why?
|
Conjugation, Genetic | 1 | 2024 | 22 | 0.060 |
Why?
|
Vipoma | 1 | 1983 | 4 | 0.060 |
Why?
|
Radioligand Assay | 1 | 2004 | 32 | 0.060 |
Why?
|
Heptanes | 1 | 2003 | 2 | 0.060 |
Why?
|
Adenoma, Islet Cell | 1 | 1983 | 28 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2005 | 210 | 0.060 |
Why?
|
Arterial Pressure | 1 | 2024 | 39 | 0.060 |
Why?
|
Amines | 1 | 2024 | 28 | 0.060 |
Why?
|
Trypsin | 1 | 2004 | 95 | 0.060 |
Why?
|
1-Methyl-3-isobutylxanthine | 2 | 1996 | 16 | 0.060 |
Why?
|
Amides | 1 | 2024 | 53 | 0.060 |
Why?
|
Lipopolysaccharide Receptors | 1 | 2003 | 23 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1994 | 269 | 0.060 |
Why?
|
Protective Agents | 1 | 2004 | 33 | 0.060 |
Why?
|
Delivery, Obstetric | 1 | 2024 | 118 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2006 | 230 | 0.060 |
Why?
|
Pyloric Antrum | 1 | 2003 | 4 | 0.060 |
Why?
|
Surface-Active Agents | 1 | 2004 | 60 | 0.060 |
Why?
|
Colony Count, Microbial | 2 | 2014 | 46 | 0.060 |
Why?
|
Amyloid | 1 | 2024 | 87 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2017 | 315 | 0.060 |
Why?
|
Reactive Oxygen Species | 2 | 2018 | 487 | 0.060 |
Why?
|
Receptors, Interleukin-11 | 1 | 2003 | 1 | 0.060 |
Why?
|
Interleukin-11 Receptor alpha Subunit | 1 | 2003 | 1 | 0.060 |
Why?
|
Octoxynol | 1 | 2003 | 8 | 0.060 |
Why?
|
Catalysis | 1 | 2024 | 205 | 0.060 |
Why?
|
Head | 1 | 2024 | 135 | 0.060 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2024 | 85 | 0.060 |
Why?
|
Epilepsy | 1 | 2008 | 421 | 0.060 |
Why?
|
Detergents | 1 | 2003 | 34 | 0.060 |
Why?
|
Metronidazole | 1 | 2003 | 26 | 0.060 |
Why?
|
Receptors, Interleukin | 1 | 2003 | 36 | 0.060 |
Why?
|
Cesarean Section | 1 | 2024 | 140 | 0.060 |
Why?
|
Cytochrome P-450 CYP2E1 | 1 | 2023 | 4 | 0.060 |
Why?
|
Methotrexate | 1 | 2004 | 250 | 0.060 |
Why?
|
Leukocyte Rolling | 2 | 2012 | 2 | 0.060 |
Why?
|
Flow Cytometry | 3 | 2014 | 691 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2014 | 902 | 0.050 |
Why?
|
Prostate | 1 | 2007 | 392 | 0.050 |
Why?
|
Densitometry | 1 | 2003 | 29 | 0.050 |
Why?
|
Colforsin | 3 | 2003 | 74 | 0.050 |
Why?
|
Triglycerides | 2 | 2016 | 232 | 0.050 |
Why?
|
DNA Transposable Elements | 1 | 2024 | 174 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2003 | 92 | 0.050 |
Why?
|
CD28 Antigens | 1 | 2003 | 90 | 0.050 |
Why?
|
Bethanechol | 2 | 1992 | 2 | 0.050 |
Why?
|
Amino Acids | 1 | 2024 | 252 | 0.050 |
Why?
|
Morphine | 1 | 1984 | 130 | 0.050 |
Why?
|
Enterocytes | 1 | 2002 | 18 | 0.050 |
Why?
|
Receptors, Steroid | 1 | 2003 | 42 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 431 | 0.050 |
Why?
|
Darkness | 1 | 2022 | 49 | 0.050 |
Why?
|
Protein Structure, Tertiary | 3 | 2012 | 741 | 0.050 |
Why?
|
Multiple Organ Failure | 1 | 2003 | 54 | 0.050 |
Why?
|
Body Temperature Regulation | 1 | 2022 | 56 | 0.050 |
Why?
|
Base Sequence | 4 | 2012 | 2331 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2006 | 603 | 0.050 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2002 | 85 | 0.050 |
Why?
|
Cell Count | 1 | 2002 | 199 | 0.050 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2003 | 160 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 289 | 0.050 |
Why?
|
Stimulation, Chemical | 2 | 1993 | 63 | 0.050 |
Why?
|
Virus Inactivation | 1 | 2021 | 4 | 0.050 |
Why?
|
Antigen-Antibody Reactions | 1 | 2021 | 23 | 0.050 |
Why?
|
Phosphatidylethanolamines | 1 | 2021 | 15 | 0.050 |
Why?
|
Semiconductors | 1 | 2021 | 11 | 0.050 |
Why?
|
Anastomotic Leak | 1 | 2023 | 101 | 0.050 |
Why?
|
Keratinocytes | 1 | 2003 | 145 | 0.050 |
Why?
|
Thiadiazoles | 1 | 2021 | 12 | 0.050 |
Why?
|
Meconium | 2 | 2013 | 15 | 0.050 |
Why?
|
Gene Ontology | 1 | 2021 | 34 | 0.050 |
Why?
|
DNA Damage | 2 | 2014 | 371 | 0.050 |
Why?
|
Thionucleotides | 2 | 1999 | 56 | 0.050 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2001 | 3 | 0.050 |
Why?
|
Hypertrophy | 1 | 2021 | 67 | 0.050 |
Why?
|
Photoperiod | 1 | 2022 | 73 | 0.050 |
Why?
|
Histones | 2 | 2014 | 327 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2021 | 75 | 0.050 |
Why?
|
Spike Glycoprotein, Coronavirus | 1 | 2021 | 44 | 0.050 |
Why?
|
Cyclic AMP Response Element Modulator | 2 | 2012 | 3 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2021 | 105 | 0.050 |
Why?
|
Chemokines | 1 | 2021 | 74 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2001 | 83 | 0.050 |
Why?
|
Nitrogen Oxides | 1 | 2001 | 15 | 0.050 |
Why?
|
Ammonia | 1 | 2001 | 38 | 0.050 |
Why?
|
Spermine | 1 | 2001 | 21 | 0.050 |
Why?
|
Ouabain | 1 | 2001 | 24 | 0.050 |
Why?
|
Proof of Concept Study | 1 | 2021 | 43 | 0.050 |
Why?
|
Arachidonic Acid | 2 | 1992 | 63 | 0.050 |
Why?
|
Lasers | 1 | 2021 | 107 | 0.050 |
Why?
|
Iron Chelating Agents | 1 | 2001 | 4 | 0.050 |
Why?
|
Rubidium Radioisotopes | 1 | 2001 | 4 | 0.050 |
Why?
|
Muscles | 2 | 2014 | 193 | 0.050 |
Why?
|
Bicarbonates | 2 | 1995 | 58 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2005 | 1096 | 0.050 |
Why?
|
HCT116 Cells | 2 | 2015 | 155 | 0.050 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 254 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2002 | 212 | 0.050 |
Why?
|
Patient Satisfaction | 2 | 2019 | 460 | 0.050 |
Why?
|
Ontario | 1 | 2020 | 52 | 0.050 |
Why?
|
Theophylline | 2 | 1992 | 33 | 0.050 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2022 | 109 | 0.050 |
Why?
|
Breast Density | 1 | 2020 | 35 | 0.050 |
Why?
|
Polymers | 1 | 2021 | 194 | 0.050 |
Why?
|
Iodine Radioisotopes | 1 | 2001 | 134 | 0.050 |
Why?
|
Dyslipidemias | 1 | 2021 | 108 | 0.050 |
Why?
|
Infant, Premature | 2 | 2015 | 295 | 0.040 |
Why?
|
Cell Fractionation | 2 | 2004 | 71 | 0.040 |
Why?
|
Vancomycin | 1 | 2020 | 73 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2020 | 93 | 0.040 |
Why?
|
Prostate-Specific Antigen | 1 | 2002 | 358 | 0.040 |
Why?
|
Carbachol | 3 | 1990 | 36 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2020 | 52 | 0.040 |
Why?
|
Organic Chemicals | 1 | 2019 | 34 | 0.040 |
Why?
|
Models, Molecular | 3 | 2012 | 1295 | 0.040 |
Why?
|
Intracellular Fluid | 1 | 1999 | 34 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2020 | 48 | 0.040 |
Why?
|
Cholestasis | 1 | 2020 | 47 | 0.040 |
Why?
|
Home Care Services | 1 | 2020 | 73 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2020 | 140 | 0.040 |
Why?
|
Substance P | 3 | 1990 | 61 | 0.040 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2019 | 10 | 0.040 |
Why?
|
Face | 1 | 2020 | 116 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1985 | 562 | 0.040 |
Why?
|
DNA, Complementary | 2 | 1997 | 392 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 1999 | 68 | 0.040 |
Why?
|
Patients | 1 | 2020 | 102 | 0.040 |
Why?
|
Interferon Type I | 1 | 2020 | 178 | 0.040 |
Why?
|
Enterococcus faecalis | 1 | 2019 | 54 | 0.040 |
Why?
|
Patient Dropouts | 1 | 2019 | 30 | 0.040 |
Why?
|
Peroxidase | 1 | 2019 | 51 | 0.040 |
Why?
|
Streptozocin | 2 | 2017 | 55 | 0.040 |
Why?
|
Qualitative Research | 1 | 2020 | 285 | 0.040 |
Why?
|
ARNTL Transcription Factors | 1 | 2018 | 11 | 0.040 |
Why?
|
PPAR alpha | 1 | 2018 | 10 | 0.040 |
Why?
|
Computer Simulation | 2 | 2015 | 1095 | 0.040 |
Why?
|
Mitochondria | 1 | 2002 | 552 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2020 | 243 | 0.040 |
Why?
|
Hypertonic Solutions | 2 | 1999 | 17 | 0.040 |
Why?
|
Parotid Gland | 1 | 1999 | 32 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2018 | 48 | 0.040 |
Why?
|
Calcimycin | 2 | 1990 | 33 | 0.040 |
Why?
|
Chick Embryo | 1 | 1999 | 230 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2018 | 66 | 0.040 |
Why?
|
Second Messenger Systems | 1 | 1998 | 41 | 0.040 |
Why?
|
Potassium Channels | 1 | 2001 | 343 | 0.040 |
Why?
|
Mineralocorticoids | 1 | 1998 | 7 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 1039 | 0.040 |
Why?
|
Penetrance | 1 | 2018 | 45 | 0.040 |
Why?
|
RNA Stability | 1 | 2018 | 89 | 0.040 |
Why?
|
Adrenergic alpha-Agonists | 2 | 2009 | 33 | 0.040 |
Why?
|
Benzyl Alcohol | 1 | 1997 | 3 | 0.040 |
Why?
|
Radiography | 2 | 2013 | 807 | 0.040 |
Why?
|
Trifluoperazine | 2 | 1989 | 10 | 0.040 |
Why?
|
Sodium Salicylate | 1 | 1997 | 4 | 0.040 |
Why?
|
Imidazoles | 2 | 1990 | 151 | 0.040 |
Why?
|
Dioxygenases | 1 | 2018 | 75 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2019 | 267 | 0.040 |
Why?
|
Neuroimmunomodulation | 1 | 2017 | 11 | 0.040 |
Why?
|
Duodenum | 2 | 1988 | 102 | 0.040 |
Why?
|
Program Evaluation | 1 | 2019 | 303 | 0.040 |
Why?
|
Phytotherapy | 1 | 2019 | 135 | 0.040 |
Why?
|
Electrocardiography | 1 | 2020 | 495 | 0.040 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2001 | 71 | 0.040 |
Why?
|
Genistein | 1 | 2017 | 16 | 0.040 |
Why?
|
Ammonium Chloride | 2 | 1996 | 21 | 0.040 |
Why?
|
Diazooxonorleucine | 1 | 1997 | 5 | 0.040 |
Why?
|
beta-Galactosidase | 1 | 2017 | 73 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 1234 | 0.040 |
Why?
|
Catalase | 1 | 2017 | 49 | 0.040 |
Why?
|
Gene Deletion | 1 | 2018 | 342 | 0.040 |
Why?
|
Metabolomics | 1 | 2017 | 73 | 0.040 |
Why?
|
Capillary Permeability | 1 | 2018 | 130 | 0.040 |
Why?
|
Methyltransferases | 1 | 2018 | 192 | 0.040 |
Why?
|
Mammography | 1 | 2020 | 468 | 0.040 |
Why?
|
Heart Rate | 1 | 2020 | 492 | 0.040 |
Why?
|
Survival Analysis | 2 | 2012 | 1542 | 0.040 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 75 | 0.040 |
Why?
|
Superoxides | 1 | 2017 | 74 | 0.040 |
Why?
|
RNA, Complementary | 1 | 1996 | 8 | 0.040 |
Why?
|
Body Mass Index | 1 | 2020 | 770 | 0.040 |
Why?
|
Plant Roots | 1 | 2017 | 107 | 0.040 |
Why?
|
Lactobacillaceae | 1 | 2016 | 2 | 0.040 |
Why?
|
Inactivation, Metabolic | 1 | 2016 | 8 | 0.040 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 28 | 0.040 |
Why?
|
Genes, Bacterial | 2 | 2012 | 198 | 0.040 |
Why?
|
Muscle Denervation | 1 | 1996 | 3 | 0.040 |
Why?
|
Telomerase | 1 | 2017 | 61 | 0.040 |
Why?
|
Manometry | 2 | 2007 | 44 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 1352 | 0.040 |
Why?
|
Malabsorption Syndromes | 1 | 1996 | 21 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2017 | 273 | 0.040 |
Why?
|
NADPH Oxidases | 1 | 2017 | 82 | 0.040 |
Why?
|
Patient Care Team | 1 | 2019 | 283 | 0.040 |
Why?
|
HeLa Cells | 1 | 1998 | 507 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 111 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2020 | 548 | 0.040 |
Why?
|
Gastrointestinal Hormones | 1 | 2016 | 6 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 110 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1997 | 647 | 0.030 |
Why?
|
Tunicamycin | 1 | 1996 | 13 | 0.030 |
Why?
|
Pyocyanine | 2 | 2007 | 12 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2016 | 83 | 0.030 |
Why?
|
Lymphatic System | 1 | 1996 | 55 | 0.030 |
Why?
|
Dihydrolipoamide Dehydrogenase | 1 | 1996 | 4 | 0.030 |
Why?
|
Opportunistic Infections | 1 | 1996 | 59 | 0.030 |
Why?
|
Isopropyl Thiogalactoside | 1 | 1996 | 3 | 0.030 |
Why?
|
Captopril | 1 | 1996 | 20 | 0.030 |
Why?
|
Genital Neoplasms, Female | 1 | 2017 | 108 | 0.030 |
Why?
|
Didelphis | 2 | 2006 | 3 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2019 | 342 | 0.030 |
Why?
|
Leptin | 1 | 2016 | 105 | 0.030 |
Why?
|
Tetrodotoxin | 1 | 1996 | 50 | 0.030 |
Why?
|
Toll-Like Receptor 1 | 1 | 2016 | 7 | 0.030 |
Why?
|
Ligation | 2 | 2006 | 51 | 0.030 |
Why?
|
Thermogenesis | 1 | 2016 | 41 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 6723 | 0.030 |
Why?
|
Intra-Abdominal Fat | 1 | 2016 | 31 | 0.030 |
Why?
|
Mitochondrial Size | 1 | 2015 | 3 | 0.030 |
Why?
|
Ions | 1 | 1996 | 75 | 0.030 |
Why?
|
Nuclear Respiratory Factor 1 | 1 | 2015 | 6 | 0.030 |
Why?
|
Age Factors | 1 | 2020 | 1863 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2017 | 112 | 0.030 |
Why?
|
HT29 Cells | 1 | 2015 | 50 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2016 | 199 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 1996 | 46 | 0.030 |
Why?
|
Genes, myc | 1 | 2015 | 39 | 0.030 |
Why?
|
Isoenzymes | 1 | 1996 | 273 | 0.030 |
Why?
|
Proton-Translocating ATPases | 1 | 1995 | 23 | 0.030 |
Why?
|
Computing Methodologies | 1 | 2015 | 9 | 0.030 |
Why?
|
Abdominal Muscles | 1 | 2015 | 19 | 0.030 |
Why?
|
Publishing | 1 | 1996 | 91 | 0.030 |
Why?
|
Heart Diseases | 1 | 2017 | 297 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2015 | 92 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 96 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2015 | 100 | 0.030 |
Why?
|
Microsomes | 1 | 1994 | 35 | 0.030 |
Why?
|
Pilot Projects | 1 | 2017 | 866 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2015 | 78 | 0.030 |
Why?
|
Sodium-Glucose Transporter 1 | 2 | 2004 | 4 | 0.030 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1994 | 27 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 1994 | 181 | 0.030 |
Why?
|
Adrenalectomy | 1 | 1994 | 45 | 0.030 |
Why?
|
Foam Cells | 1 | 2014 | 17 | 0.030 |
Why?
|
Peptide Hormones | 2 | 2005 | 29 | 0.030 |
Why?
|
Poly (ADP-Ribose) Polymerase-1 | 1 | 2014 | 25 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2014 | 20 | 0.030 |
Why?
|
Glucose Transporter Type 5 | 1 | 1994 | 6 | 0.030 |
Why?
|
CD18 Antigens | 1 | 2014 | 22 | 0.030 |
Why?
|
Glucose Transporter Type 2 | 1 | 1994 | 11 | 0.030 |
Why?
|
Plaque, Atherosclerotic | 1 | 2015 | 59 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 1996 | 358 | 0.030 |
Why?
|
Ceruletide | 1 | 2013 | 1 | 0.030 |
Why?
|
Allergy and Immunology | 1 | 2014 | 12 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2014 | 307 | 0.030 |
Why?
|
Length of Stay | 1 | 2017 | 726 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2014 | 54 | 0.030 |
Why?
|
Periodicals as Topic | 1 | 1996 | 168 | 0.030 |
Why?
|
Diamide | 1 | 1993 | 3 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2014 | 227 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2014 | 74 | 0.030 |
Why?
|
Cytoplasm | 2 | 2004 | 285 | 0.030 |
Why?
|
B-Cell CLL-Lymphoma 10 Protein | 1 | 2013 | 8 | 0.030 |
Why?
|
Adenosine Diphosphate Ribose | 1 | 1993 | 8 | 0.030 |
Why?
|
Radioisotopes | 1 | 1993 | 45 | 0.030 |
Why?
|
Arginine | 1 | 2013 | 138 | 0.030 |
Why?
|
Nitrites | 1 | 1993 | 30 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2013 | 26 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2014 | 139 | 0.030 |
Why?
|
E-Selectin | 1 | 2013 | 30 | 0.030 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2013 | 45 | 0.030 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2012 | 25 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2016 | 1051 | 0.030 |
Why?
|
Chlorine | 1 | 1992 | 8 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 1993 | 71 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 1993 | 93 | 0.030 |
Why?
|
Rats, Transgenic | 1 | 2012 | 6 | 0.030 |
Why?
|
HLA-B27 Antigen | 1 | 2012 | 8 | 0.030 |
Why?
|
Cell Death | 1 | 2013 | 262 | 0.030 |
Why?
|
Microbial Viability | 1 | 2012 | 32 | 0.030 |
Why?
|
Food Deprivation | 1 | 1992 | 24 | 0.030 |
Why?
|
Thymidine | 1 | 1992 | 60 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 1992 | 66 | 0.030 |
Why?
|
Sodium-Bicarbonate Symporters | 1 | 2012 | 7 | 0.030 |
Why?
|
Hyperphagia | 1 | 1992 | 36 | 0.030 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2012 | 22 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 1994 | 565 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 1992 | 117 | 0.030 |
Why?
|
MAP Kinase Kinase 5 | 1 | 2012 | 12 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 166 | 0.030 |
Why?
|
Drug Synergism | 1 | 2012 | 305 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2012 | 159 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 1992 | 133 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2012 | 88 | 0.030 |
Why?
|
Nucleotides, Cyclic | 1 | 1992 | 11 | 0.030 |
Why?
|
Interleukin-23 | 1 | 2012 | 57 | 0.030 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1992 | 28 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2012 | 140 | 0.030 |
Why?
|
Glucocorticoids | 1 | 1994 | 358 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 80 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 283 | 0.030 |
Why?
|
Ubiquitination | 1 | 2012 | 70 | 0.030 |
Why?
|
Hydrogen Bonding | 1 | 2012 | 144 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2012 | 95 | 0.030 |
Why?
|
Subcellular Fractions | 1 | 1991 | 94 | 0.030 |
Why?
|
Histamine | 1 | 1992 | 126 | 0.020 |
Why?
|
DNA Probes | 1 | 1991 | 77 | 0.020 |
Why?
|
Acute Disease | 1 | 2013 | 838 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 157 | 0.020 |
Why?
|
Methionine | 1 | 1991 | 65 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 589 | 0.020 |
Why?
|
DNA Replication | 1 | 1992 | 169 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2012 | 342 | 0.020 |
Why?
|
Skin Transplantation | 1 | 2012 | 182 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 1694 | 0.020 |
Why?
|
5-Lipoxygenase-Activating Proteins | 1 | 1990 | 1 | 0.020 |
Why?
|
Quality of Life | 1 | 2019 | 1649 | 0.020 |
Why?
|
Mucus | 1 | 2010 | 19 | 0.020 |
Why?
|
Myristoylated Alanine-Rich C Kinase Substrate | 1 | 1990 | 3 | 0.020 |
Why?
|
Acylation | 1 | 1990 | 40 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 1709 | 0.020 |
Why?
|
Protein Stability | 1 | 2010 | 101 | 0.020 |
Why?
|
Isoquinolines | 1 | 1990 | 73 | 0.020 |
Why?
|
Inositol Phosphates | 1 | 1990 | 16 | 0.020 |
Why?
|
Pancreatic Diseases | 1 | 2010 | 51 | 0.020 |
Why?
|
Cell Cycle | 1 | 2012 | 508 | 0.020 |
Why?
|
Exons | 1 | 1991 | 452 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 261 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 2019 | 0.020 |
Why?
|
Fungal Proteins | 1 | 1990 | 141 | 0.020 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2009 | 31 | 0.020 |
Why?
|
Ionomycin | 1 | 2009 | 21 | 0.020 |
Why?
|
Intracellular Space | 1 | 2009 | 38 | 0.020 |
Why?
|
Bacteriocins | 1 | 2009 | 12 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1990 | 164 | 0.020 |
Why?
|
Hemolysin Proteins | 1 | 2009 | 34 | 0.020 |
Why?
|
Skin | 1 | 2012 | 581 | 0.020 |
Why?
|
Myelin Sheath | 1 | 2009 | 85 | 0.020 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2008 | 7 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2009 | 99 | 0.020 |
Why?
|
Polysaccharides | 1 | 2009 | 90 | 0.020 |
Why?
|
Whey Proteins | 1 | 2008 | 8 | 0.020 |
Why?
|
Vitamin D3 24-Hydroxylase | 1 | 2008 | 6 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2009 | 79 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2008 | 44 | 0.020 |
Why?
|
Oligodendroglia | 1 | 2009 | 124 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2008 | 69 | 0.020 |
Why?
|
Ketoconazole | 1 | 2008 | 26 | 0.020 |
Why?
|
Fluoresceins | 1 | 1988 | 43 | 0.020 |
Why?
|
Calcium Channels | 1 | 1990 | 182 | 0.020 |
Why?
|
Sucrose | 1 | 2008 | 65 | 0.020 |
Why?
|
Octreotide | 1 | 1988 | 17 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2010 | 319 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2009 | 332 | 0.020 |
Why?
|
Electrophysiology | 2 | 1993 | 402 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2009 | 174 | 0.020 |
Why?
|
Overweight | 1 | 2008 | 118 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2009 | 487 | 0.020 |
Why?
|
Protein Conformation | 1 | 1990 | 884 | 0.020 |
Why?
|
Nigericin | 1 | 1987 | 2 | 0.020 |
Why?
|
Valinomycin | 1 | 1987 | 8 | 0.020 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2007 | 10 | 0.020 |
Why?
|
Buffers | 1 | 1987 | 26 | 0.020 |
Why?
|
Defecation | 1 | 2007 | 23 | 0.020 |
Why?
|
Peristalsis | 1 | 2006 | 10 | 0.020 |
Why?
|
Cathartics | 1 | 2007 | 27 | 0.020 |
Why?
|
Chloride Channels | 1 | 2007 | 42 | 0.020 |
Why?
|
Glycine | 1 | 1987 | 94 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2008 | 112 | 0.020 |
Why?
|
Denervation | 1 | 1986 | 24 | 0.020 |
Why?
|
Chelating Agents | 1 | 1987 | 69 | 0.020 |
Why?
|
Inosine | 1 | 2006 | 19 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 575 | 0.020 |
Why?
|
Gallopamil | 1 | 1986 | 1 | 0.020 |
Why?
|
Bombesin | 1 | 1986 | 6 | 0.020 |
Why?
|
Neurotensin | 1 | 1986 | 10 | 0.020 |
Why?
|
Antigens, CD | 2 | 2002 | 466 | 0.020 |
Why?
|
Action Potentials | 1 | 1990 | 593 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2007 | 157 | 0.020 |
Why?
|
Pressure | 1 | 2006 | 166 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2006 | 170 | 0.020 |
Why?
|
Gastroepiploic Artery | 1 | 2005 | 1 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2005 | 20 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2005 | 5 | 0.020 |
Why?
|
Stomach | 1 | 2006 | 110 | 0.020 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2005 | 42 | 0.020 |
Why?
|
Echocardiography | 1 | 2010 | 933 | 0.020 |
Why?
|
Treatment Failure | 1 | 2006 | 289 | 0.020 |
Why?
|
Phosphothreonine | 1 | 2004 | 3 | 0.020 |
Why?
|
fas Receptor | 1 | 2005 | 77 | 0.020 |
Why?
|
Atrophy | 1 | 2005 | 118 | 0.020 |
Why?
|
Aorta | 1 | 2006 | 286 | 0.020 |
Why?
|
Narcotics | 1 | 1985 | 70 | 0.010 |
Why?
|
Morphine Dependence | 1 | 1984 | 1 | 0.010 |
Why?
|
Hexamethonium Compounds | 1 | 1984 | 6 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 46 | 0.010 |
Why?
|
Atropine | 1 | 1984 | 60 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2004 | 177 | 0.010 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 24 | 0.010 |
Why?
|
Quaternary Ammonium Compounds | 1 | 1984 | 80 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 39 | 0.010 |
Why?
|
Indomethacin | 1 | 2003 | 59 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 697 | 0.010 |
Why?
|
Nuclear Receptor Subfamily 2, Group C, Member 1 | 1 | 2003 | 1 | 0.010 |
Why?
|
Peroxisome Proliferators | 1 | 2003 | 2 | 0.010 |
Why?
|
Guanosine Triphosphate | 1 | 1983 | 38 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2002 | 90 | 0.010 |
Why?
|
Tocopherols | 1 | 2002 | 6 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2003 | 314 | 0.010 |
Why?
|
Naltrexone | 1 | 1984 | 136 | 0.010 |
Why?
|
Retinoid X Receptors | 1 | 2002 | 39 | 0.010 |
Why?
|
Methoxamine | 1 | 1982 | 3 | 0.010 |
Why?
|
Phentolamine | 1 | 1982 | 8 | 0.010 |
Why?
|
Receptors, Retinoic Acid | 1 | 2002 | 46 | 0.010 |
Why?
|
Prazosin | 1 | 1982 | 10 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2005 | 205 | 0.010 |
Why?
|
Tretinoin | 1 | 2003 | 128 | 0.010 |
Why?
|
Phenylephrine | 1 | 1982 | 36 | 0.010 |
Why?
|
COS Cells | 1 | 2002 | 167 | 0.010 |
Why?
|
Dimerization | 1 | 2002 | 143 | 0.010 |
Why?
|
Propranolol | 1 | 1982 | 44 | 0.010 |
Why?
|
Epinephrine | 1 | 1982 | 86 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2002 | 411 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2003 | 290 | 0.010 |
Why?
|
Ligands | 1 | 2003 | 440 | 0.010 |
Why?
|
Computational Biology | 1 | 2004 | 542 | 0.010 |
Why?
|
Bacterial Translocation | 1 | 2000 | 26 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2001 | 508 | 0.010 |
Why?
|
Exotoxins | 1 | 2000 | 20 | 0.010 |
Why?
|
Pyrimidines | 1 | 2003 | 372 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2006 | 3655 | 0.010 |
Why?
|
Laparoscopy | 1 | 2006 | 766 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2004 | 726 | 0.010 |
Why?
|
Okadaic Acid | 1 | 1999 | 10 | 0.010 |
Why?
|
Culture Techniques | 1 | 1999 | 91 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1999 | 50 | 0.010 |
Why?
|
Blood | 1 | 1999 | 69 | 0.010 |
Why?
|
LLC-PK1 Cells | 1 | 1996 | 1 | 0.010 |
Why?
|
Xenopus laevis | 1 | 1996 | 137 | 0.010 |
Why?
|
Clone Cells | 1 | 1996 | 214 | 0.010 |
Why?
|
RNA Probes | 1 | 1995 | 16 | 0.010 |
Why?
|
Growth Substances | 1 | 1995 | 80 | 0.010 |
Why?
|
Alkalosis | 1 | 1995 | 10 | 0.010 |
Why?
|
Rodentia | 1 | 1994 | 42 | 0.010 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1994 | 58 | 0.010 |
Why?
|
Glutathione | 1 | 1993 | 109 | 0.010 |
Why?
|
Thy-1 Antigens | 1 | 1992 | 16 | 0.010 |
Why?
|
CD5 Antigens | 1 | 1992 | 14 | 0.010 |
Why?
|
Histocompatibility Antigens | 1 | 1992 | 38 | 0.010 |
Why?
|
CD8 Antigens | 1 | 1992 | 82 | 0.010 |
Why?
|
Lymphokines | 1 | 1992 | 76 | 0.010 |
Why?
|
Antigens, Surface | 1 | 1992 | 103 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1992 | 95 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1992 | 100 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 103 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1992 | 389 | 0.010 |
Why?
|
Calcium Radioisotopes | 1 | 1988 | 4 | 0.010 |
Why?
|
Methylglucosides | 1 | 1987 | 1 | 0.000 |
Why?
|
3-O-Methylglucose | 1 | 1987 | 2 | 0.000 |
Why?
|
Phlorhizin | 1 | 1987 | 3 | 0.000 |
Why?
|
Sympathectomy, Chemical | 1 | 1987 | 6 | 0.000 |
Why?
|
Hydroxydopamines | 1 | 1987 | 7 | 0.000 |
Why?
|
Oxidopamine | 1 | 1987 | 8 | 0.000 |
Why?
|
Sulfates | 1 | 1987 | 57 | 0.000 |
Why?
|
Alanine | 1 | 1987 | 85 | 0.000 |
Why?
|
Ion Exchange | 1 | 1985 | 6 | 0.000 |
Why?
|
Tyramine | 1 | 1985 | 4 | 0.000 |
Why?
|
Enkephalin, Methionine | 1 | 1985 | 5 | 0.000 |
Why?
|
Kinins | 1 | 1985 | 31 | 0.000 |
Why?
|
Receptors, Opioid | 1 | 1985 | 23 | 0.000 |
Why?
|